アフラックの適時開示・決算・その他

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 1, 2023

Aflac Incorporated

_________________________________________________________________________________________________________________________________________________________

(Exact name of registrant as specified in its charter)

Georgia

001-07434

58-1167100

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

1932 Wynnton Road

Columbus

Georgia

31999

(Address of principal executive offices)

(Zip Code)

706.323.3431

_________________________________________________________________________________________________________________________________________________________

(Registrant’s telephone number, including area code)

_________________________________________________________________________________________________________________________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.10 Par Value

AFL

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02 Results of Operations and Financial Condition.

Aflac Incorporated (the "Company") is furnishing its press release dated November 1, 2023 in which it reported its 2023 third quarter results herein as Exhibit 99.1 to this report. The Company is also furnishing its third quarter supplemental earnings materials as Exhibit 99.2 to this report.

On November 1, 2023, the Company posted to its investor relations website at investors.aflac.com a video presentation by Max Brodén, the Company's Executive Vice President and Chief Financial Officer, discussing the Company's 2023 third quarter earnings. The Company is furnishing a transcript of Mr. Brodén's comments and a copy of the slides referenced in the presentation as Exhibit 99.3 and Exhibit 99.4, respectively, to this report.

In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.


Exhibit Number						Exhibit Title or Description
99.1						Press release of Aflac Incorporated dated November 1, 2023
99.2						Financial Supplement for Third Quarter 2023
99.3						Transcript of comments in video presentation by Max Brodén, Executive Vice President and Chief Financial Officer of Aflac Incorporated.
99.4						Slides referenced in video presentation by Max Brodén, Executive Vice President and Chief Financial Officer of Aflac Incorporated.
104						Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Aflac Incorporated

November 1, 2023

/s/ June Howard

(June Howard)

Senior Vice President, Financial Services

Chief Accounting Officer

EX-99.1 2 aflex991-q32023.htm EX-99.1 Document

News Release

Aflac Incorporated Announces Third Quarter Results,

Reports Third Quarter Net Earnings of $1.6 Billion,

Declares Fourth Quarter Dividend,

Increases First Quarter 2024 Dividend 19%

COLUMBUS, Ga. - November 1, 2023 - Aflac Incorporated (NYSE: AFL) today reported its third quarter results.

Total revenues were $5.0 billion in the third quarter of 2023, compared with $4.7 billion in the third quarter of 2022. Net earnings were $1.6 billion, or $2.64 per diluted share, compared with $1.8 billion, or $2.82 per diluted share a year ago.

Net earnings in the third quarter of 2023 included net investment gains of $423 million, or $0.71 per diluted share, compared with net investment gains of $199 million, or $0.31 per diluted share a year ago. These net investment gains were driven by net gains on certain derivatives and foreign currency activities of $381 million, largely driven by changes in exchange rates, a $47 million gain from an increase in the fair value of equity securities and $24 million of net gains from sales and redemptions. Net investment losses included a $29 million increase in the company's current expected credit losses (CECL) reserves and impairments.

Adjusted earnings* in the third quarter were $1.1 billion, compared with $910 million in the third quarter of 2022, reflecting an increase of 20.3%. Adjusted earnings per diluted share* increased 27.8% to $1.84 in the quarter. Variable investment income ran $13 million, or $0.02 per share, below the company's long-term return expectations. The weaker yen/dollar exchange rate negatively impacted adjusted earnings per share by $0.06.

The average yen/dollar exchange rate in the third quarter of 2023 was 144.97, or 5.4% weaker than the average rate of 137.08 in the third quarter of 2022. For the first nine months, the average exchange rate was 138.38, or 8.5% weaker than the rate of 126.65 a year ago.

Total investments and cash at the end of September 2023 were $111.3 billion, compared with $114.5 billion at September 30, 2022. The decline in the carrying amount of the portfolio is principally driven by the rise in interest rates and weakening of yen exchange rates.

Shareholders’ equity was $22.7 billion, or $38.63 per share, at September 30, 2023, compared with $19.9 billion, or $31.97 per share, at September 30, 2022. Shareholders’ equity at the end of the third quarter included a cumulative decrease of $866 million for the effect of the change in discount rate assumptions on insurance reserves, compared with a corresponding cumulative decrease of $4.1 billion at September 30, 2022 and a net unrealized loss on investment securities and derivatives of $427 million, compared with a net unrealized gain of $1.1 billion at September 30, 2022. Shareholders’ equity at the end of the third quarter also included an unrealized foreign currency translation loss of $4.5 billion, compared with an unrealized foreign currency translation loss of $4.4 billion at September 30, 2022. The annualized return on average shareholders’ equity in the third quarter was 29.1%.

For the first nine months of 2023, total revenues were down 1.8% to $14.9 billion, compared with $15.2 billion in the first nine months of 2022. Net earnings were $4.4 billion, or $7.28 per diluted share, compared with $4.2 billion, or $6.57 per diluted share, for the first nine months of 2022. Adjusted earnings for the first nine months of 2023 were $3.0 billion, or $4.97 per diluted share, compared with $2.8 billion, or $4.35 per diluted share, in 2022. Excluding the negative impact of $0.17 per share from the weaker yen/dollar exchange rate, adjusted earnings per diluted share increased 18.2% to $5.14 for the first nine months of 2023.

Shareholders’ equity excluding AOCI (or adjusted book value*) was $28.4 billion, or $48.44 per share at September 30, 2023, compared with $27.5 billion, or $44.00 per share, at September 30, 2022. The annualized adjusted return on equity excluding foreign currency impact* in the third quarter was 16.1%.

AFLAC JAPAN

In yen terms, Aflac Japan's net earned premiums were ¥285.3 billion for the quarter, or 2.8% lower than a year ago, mainly due to limited pay products reaching paid-up status and a reinsurance transaction in the first quarter partially offset by an unlock of future deferred profit liability assumptions. Adjusted net investment income increased 7.2% to ¥98.9 billion, mainly due to higher variable investment income and floating rate income. Total adjusted revenues in yen declined 0.5% to ¥385.4 billion. Pretax adjusted earnings in yen for the quarter increased 11.4% on a reported basis to ¥126.4 billion, primarily due to lower benefits and expenses partially offset by decreased revenue during the quarter. Pretax adjusted earnings increased 7.0% on a currency-neutral basis. The pretax adjusted profit margin for the Japan segment increased to 32.8%, compared with 29.3% a year ago.

For the first nine months, net earned premiums in yen were ¥855.7 billion, or 5.0% lower than a year ago. Adjusted net investment income increased 0.9% to ¥267.8 billion. Total adjusted revenues in yen were down 3.6% to ¥1.1 trillion. Pretax adjusted earnings were ¥344.1 billion, or 4.9% higher than a year ago.

In dollar terms, net earned premiums decreased 7.2% to $2.0 billion in the third quarter. Adjusted net investment income increased 2.4% to $679 million. Total adjusted revenues declined by 4.9% to $2.7 billion. Pretax adjusted earnings increased 6.4% to $869 million.

For the first nine months, net earned premiums in dollars were $6.2 billion, or 12.4% lower than a year ago. Adjusted net investment income decreased 6.7% to $1.9 billion. Total adjusted revenues were down 11.1% to $8.2 billion. Pretax adjusted earnings were $2.5 billion, or 3.2% lower than a year ago.

For the quarter, total new annualized premium sales (sales) increased 12.4% to ¥15.6 billion, or $108 million, primarily reflecting the continued rollout of the new cancer product through alliance partners, driven largely by a 23% increase in cancer insurance sales. For the first nine months, total new sales increased 16.6% to ¥44.9 billion, or $325 million.

AFLAC U.S.

Aflac U.S. net earned premiums increased 3.2% to $1.4 billion in the third quarter compared to the prior year, reflecting the strong contribution from growth initiatives. Adjusted net investment income increased 13.0% to $209 million, largely due to higher variable investment income and a shift to higher-yielding fixed-income investments as well as increased floating rate income. Total adjusted revenues were up 3.9% to $1.7 billion. Pretax adjusted earnings were $478 million, 38.6% higher than a year ago, primarily due to lower benefits driven by actuarial assumption unlocks and higher adjusted net investment income, partially offset by higher adjusted expenses. Higher expenses reflected ongoing investments in the U.S. platform, as well as a write-off of certain capitalized software development costs in the third quarter of 2023. The pretax adjusted profit margin for the U.S. segment was 28.8%, compared with 21.6% a year ago.

For the first nine months, net earned premiums increased 2.2% to $4.3 billion. Adjusted net investment income increased 8.2% to $609 million. Total adjusted revenues were up 2.4% to $5.0 billion. Pretax adjusted earnings were $1.2 billion, or 17.5% higher than a year ago.

Aflac U.S. sales increased 7.5% in the quarter to $359 million, reflecting continued improvement from investment in growth initiatives as well as productivity gains. For the first nine months of the year, total new sales increased 6.4% to $998 million.

CORPORATE AND OTHER

For the quarter, total adjusted revenues increased 57.5% to $115 million compared to the prior year, primarily due to the reinsurance transaction in the first quarter of 2023 resulting in an increase to total net earned premiums, partially offset by lower net investment income driven by a higher volume of tax credit investments. Pretax adjusted earnings were a loss of $49 million, compared with a loss of $56 million a year ago, reflecting the increase in adjusted revenue, partially offset by higher total net benefit and claims and other adjusted expenses.

For the first nine months, total adjusted revenues increased 103.2% to $384 million. Pretax adjusted earnings were a loss of $107 million, compared with a loss of $173 million a year ago.

DIVIDEND AND CAPITAL RETURNED TO SHAREHOLDERS

The board of directors declared the fourth quarter dividend of $0.42 per share, payable on December 1, 2023 to shareholders of record at the close of business on November 15, 2023, and the first quarter 2024 dividend of $0.50 per share, payable on March 1, 2024 to shareholders of record at the close of business on February 21, 2024.

In the third quarter, Aflac Incorporated deployed $700 million in capital to repurchase 9.4 million of its common shares. At the end of September 2023, the company had 86.4 million remaining shares authorized for repurchase.

OUTLOOK

Commenting on the company’s results, Chairman and Chief Executive Officer Daniel P. Amos stated: "Aflac delivered very strong earnings for both the quarter and the first nine months. We have continued to actively concentrate on numerous initiatives in the U.S. and Japan around new products and distribution strategies to set the stage for future growth.

"Looking at our operations in Japan, I am pleased that our sales results reflect improvements through agencies and alliances, including Japan Post, Dai-ichi Life and Daido Life. While it's too soon to provide details about the new medical product we introduced in mid-September, early indications show that it is being well-received. Additionally, we see products like WAYS and Child Endowment as door-openers to gain new customers, which increases opportunities to sell our third sector products.

"In the U.S., I remain encouraged by the continued improvement in the productivity of our agents and brokers as well as contribution from our growth initiatives, including group life and disability; network dental and vision; and consumer markets. As we enter into the fourth quarter, which is typically our strongest quarter of the year, we continue to work toward accelerating our momentum and reinforcing our leading position.

"We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management. I am very pleased that 2023 marks 41 consecutive years of dividend increases, a record we treasure. Additionally, I am very happy with the Board's decision to increase the first quarter 2024 dividend 19%. We also remained in the market repurchasing shares at the historically high levels of the first three quarters of this year. We intend to continue our balanced approach of investing in growth initiatives and to drive long-term operating efficiencies while preserving the strength of underlying cash flows, which supports our dividend track record and tactical share repurchase."

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration insurance contracts.

*See Non-U.S. GAAP Financial Measures section for an explanation of foreign exchange and its impact on the financial statements and definitions of the non-U.S. GAAP financial measures used in this earnings release, as well as a reconciliation of such non-U.S. GAAP financial measures to the most comparable U.S. GAAP financial measures.

ABOUT AFLAC INCORPORATED

Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than 67 years to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance policies in force. The Company takes pride in being there for its policyholders when they need us most, as well as being included in 2023 in the World’s Most Ethical Companies by Ethisphere for 17 consecutive years, Fortune’s World’s Most Admired Companies for 22 years and Bloomberg’s Gender-Equality Index for the fourth consecutive year. In addition, the Company became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2022) for nine years. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/espanol. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under “Sustainability.”

1 LIMRA 2022 U.S. Supplemental Health Insurance Total Market Report

A copy of Aflac’s financial supplement for the quarter can be found on the “Investors” page at aflac.com.

Aflac Incorporated will webcast its quarterly conference call via the “Investors” page of aflac.com at 8:00 a.m. (ET) on November 2, 2023.

Note: Tables within this document may not foot due to rounding.


AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)

THREE MONTHS ENDED SEPTEMBER 30,	2023		2022		% Change
Total revenues	$	4,950	$	4,704	5.2	%
Benefits and claims, net	1,860		2,076		(10.4)
Total acquisition and operating expenses	1,285		1,299		(1.1)
Earnings before income taxes	1,805		1,329		35.8
Income taxes	236		(452)
Net earnings	$	1,569	$	1,781	(11.9)	%
Net earnings per share – basic	$	2.65	$	2.83	(6.4)	%
Net earnings per share – diluted	2.64		2.82		(6.4)
Shares used to compute earnings per share (000):
Basic	591,246		629,350		(6.1)	%
Diluted	593,596		631,946		(6.1)
Dividends paid per share	$	0.42	$	0.40	5.0	%

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.


AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)

NINE MONTHS ENDED SEPTEMBER 30,	2023		2022		% Change
Total revenues	$	14,923	$	15,192	(1.8)	%
Benefits and claims, net	6,108		6,833		(10.6)
Total acquisition and operating expenses	3,843		4,028		(4.6)
Earnings before income taxes	4,972		4,331		14.8
Income taxes	581		109
Net earnings	$	4,391	$	4,222	4.0	%
Net earnings per share – basic	$	7.31	$	6.60	10.8	%
Net earnings per share – diluted	7.28		6.57		10.8
Shares used to compute earnings per share (000):
Basic	600,991		639,862		(6.1)	%
Diluted	603,419		642,597		(6.1)
Dividends paid per share	$	1.26	$	1.20	5.0	%

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.


AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED BALANCE SHEET
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AMOUNTS)

SEPTEMBER 30,	2023		2022		% Change
Assets:
Total investments and cash	$	111,306	$	114,528	(2.8)	%
Deferred policy acquisition costs	8,771		8,666		1.2
Other assets	5,034		5,521		(8.8)
Total assets	$	125,111	$	128,715	(2.8)	%
Liabilities and shareholders’ equity:
Policy liabilities	$	86,028	$	92,586	(7.1)	%
Notes payable and lease obligations	6,961		7,518		(7.4)
Other liabilities	9,453		8,665		9.1
Shareholders’ equity	22,669		19,946		13.7
Total liabilities and shareholders’ equity	$	125,111	$	128,715	(2.8)	%
Shares outstanding at end of period (000)	586,897		623,868		(5.9)	%

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.

NON-U.S. GAAP FINANCIAL MEASURES

This document includes references to the Company’s financial performance measures which are not calculated in accordance with United States generally accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial measures exclude items that the Company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or related to infrequent activities not directly associated with insurance operations.

Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results. In periods when the yen weakens, translating yen into dollars results in fewer dollars being reported. When the yen strengthens, translating yen into dollars results in more dollars being reported. Consequently, yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the Company’s business is conducted in yen and never converted into dollars but translated into dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Management evaluates the Company's financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts and the currency-neutral operating performance over time. The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).

The company defines the non-U.S. GAAP financial measures included in this earnings release as follows:

•Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that cannot be predicted or that are outside management’s control. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest cash flows from derivatives associated with notes payable but excluding any nonrecurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company's underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.

•Adjusted earnings excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company's business is conducted in Japan and foreign exchange rates are outside management’s control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.

•Adjusted return on equity is adjusted earnings divided by average shareholders’ equity, excluding accumulated other comprehensive income (AOCI). Management uses adjusted return on equity to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of this financial measure is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The Company considers adjusted return on equity important as it excludes components of AOCI, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity is return on average equity (ROE) as determined using net earnings and average total shareholders’ equity.

•Adjusted return on equity excluding foreign currency impact is adjusted earnings excluding the current period foreign currency impact divided by average shareholders’ equity, excluding AOCI. The Company considers adjusted return on equity excluding foreign currency impact important as it excludes changes in foreign currency and components of AOCI, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity excluding foreign currency impact is ROE as determined using net earnings and average total shareholders’ equity.

•Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign exchange risks in the Company's Japan segment or in Corporate and other. These amortized hedge costs/ income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the term of the hedge. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/ income.

•Adjusted book value is the U.S. GAAP book value (representing total shareholders’ equity), less AOCI as recorded on the U.S. GAAP balance sheet. Adjusted book value per common share is adjusted book value at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value and adjusted book value per common share important as they exclude AOCI, which fluctuates due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measures for adjusted book value and adjusted book value per common share are total book value and total book value per common share, respectively.

•Adjusted book value including unrealized foreign currency translation gains and losses is adjusted book value plus unrealized foreign currency translation gains and losses. Adjusted book value including unrealized foreign currency translation gains and losses per common share is adjusted book value plus unrealized foreign currency translation gains and losses at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value including unrealized foreign currency translation gains and losses, and its related per share financial measure, important as they exclude certain components of AOCI, which fluctuate due to market movements that are outside management's control; however, it includes the impact of foreign currency as a result of the significance of Aflac’s Japan operation. The most comparable U.S. GAAP financial measures for adjusted book value including unrealized foreign currency translation gains and losses and adjusted book value including unrealized foreign currency translation gains and losses per common share are total book value and total book value per common share, respectively.

•Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company’s investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.

•Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the impact of interest cash flows from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management’s control, while excluding the components that are within management’s control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.


RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS
(UNAUDITED – IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)

THREE MONTHS ENDED SEPTEMBER 30,	2023		2022		% Change

Net earnings	$	1,569	$	1,781	(11.9)	%

Items impacting net earnings:
Adjusted net investment (gains) losses	(504)		(222)




Other and non-recurring (income) loss	(3)		(1)
Income tax (benefit) expense on items excluded from adjusted earnings 1	33		(648)



Adjusted earnings	1,095		910		20.3	%
Current period foreign currency impact 2	33		N/A
Adjusted earnings excluding current period foreign currency impact 3	$	1,128	$	910	24.0	%

Net earnings per diluted share	$	2.64	$	2.82	(6.4)	%

Items impacting net earnings:
Adjusted net investment (gains) losses	(0.85)		(0.35)
Other and non-recurring (income) loss	(0.01)		—
Income tax (benefit) expense on items excluded from adjusted earnings 1	0.06		(1.03)



Adjusted earnings per diluted share	1.84		1.44		27.8	%
Current period foreign currency impact 2	0.06		N/A
Adjusted earnings per diluted share excluding current period foreign currency impact 3	$	1.90	$	1.44	31.9	%

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.

1 Primarily reflects release of $695 million in deferred taxes in the third quarter of 2022.

2 Prior period foreign currency impact reflected as “N/A” to isolate change for current period only.

3 Amounts excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes.


RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS
(UNAUDITED – IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)

NINE MONTHS ENDED SEPTEMBER 30,	2023		2022		% Change

Net earnings	$	4,391	$	4,222	4.0	%

Items impacting net earnings:
Adjusted net investment (gains) losses	(1,363)		(923)




Other and non-recurring (income) loss	(38)		(1)
Income tax (benefit) expense on items excluded from adjusted earnings 1	12		(501)



Adjusted earnings	3,001		2,797		7.3	%
Current period foreign currency impact 2	100		N/A
Adjusted earnings excluding current period foreign currency impact 3	$	3,101	$	2,797	10.9	%

Net earnings per diluted share	$	7.28	$	6.57	10.8	%

Items impacting net earnings:
Adjusted net investment (gains) losses	(2.26)		(1.44)
Other and non-recurring (income) loss	(0.06)		—
Income tax (benefit) expense on items excluded from adjusted earnings 1	0.02		(0.78)



Adjusted earnings per diluted share	4.97		4.35		14.3	%
Current period foreign currency impact 2	0.17		N/A
Adjusted earnings excluding current period foreign currency impact 3	$	5.14	$	4.35	18.2	%

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.

1 Primarily reflects release of $695 million in deferred taxes in the third quarter of 2022.

2 Prior period foreign currency impact reflected as “N/A” to isolate change for current period only.


RECONCILIATION OF NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES
(UNAUDITED – IN MILLIONS)

THREE MONTHS ENDED SEPTEMBER 30,	2023		2022		% Change

Net investment (gains) losses	$	(423)	$	(199)	112.6	%

Items impacting net investment (gains) losses:
Amortized hedge costs	(26)		(28)
Amortized hedge income	25		19
Net interest cash flows from derivatives associated with certain investment strategies	(88)		(26)
Interest rate component of the change in fair value of foreign currency swaps on notes payable1	8		13

Adjusted net investment (gains) losses	$	(504)	$	(222)	127.0	%

1 Amounts are included with interest expenses that are a component of adjusted expenses.


RECONCILIATION OF NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME
(UNAUDITED – IN MILLIONS)

THREE MONTHS ENDED SEPTEMBER 30,	2023		2022		% Change

Net investment income	$	1,004	$	920	9.1	%

Items impacting net investment income:
Amortized hedge costs	(26)		(28)
Amortized hedge income	25		19
Net interest cash flows from derivatives associated with certain investment strategies	(88)		(26)

Adjusted net investment income	$	915	$	885	3.4	%


RECONCILIATION OF NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES
(UNAUDITED – IN MILLIONS)

NINE MONTHS ENDED SEPTEMBER 30,	2023		2022		% Change

Net investment (gains) losses	$	(1,101)	$	(885)	24.4	%

Items impacting net investment (gains) losses:
Amortized hedge costs	(148)		(84)
Amortized hedge income	92		44
Net interest cash flows from derivatives associated with certain investment strategies	(239)		(36)
Interest rate component of the change in fair value of foreign currency swaps on notes payable1	32		38

Adjusted net investment (gains) losses	$	(1,363)	$	(923)	47.7	%

1 Amounts are included with interest expenses that are a component of adjusted expenses.


RECONCILIATION OF NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME
(UNAUDITED – IN MILLIONS)

NINE MONTHS ENDED SEPTEMBER 30,	2023		2022		% Change

Net investment income	$	2,946	$	2,760	6.7	%

Items impacting net investment income:
Amortized hedge costs	(148)		(84)
Amortized hedge income	92		44
Net interest cash flows from derivatives associated with certain investment strategies	(239)		(36)

Adjusted net investment income	$	2,651	$	2,684	(1.2)	%


RECONCILIATION OF U.S. GAAP BOOK VALUE TO ADJUSTED BOOK VALUE
(UNAUDITED - IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)

SEPTEMBER 30,	2023		2022		% Change
U.S. GAAP book value	$	22,669	$	19,946
Less:
Unrealized foreign currency translation gains (losses)	(4,484)		(4,374)
Unrealized gains (losses) on securities and derivatives	(427)		1,102
Effect of changes in discount rate assumptions	(866)		(4,075)
Pension liability adjustment	17		(158)
Total AOCI	(5,760)		(7,505)
Adjusted book value	$	28,429	$	27,451
Add:
Unrealized foreign currency translation gains (losses)	(4,484)		(4,374)
Adjusted book value including unrealized foreign currency translation gains (losses)	$	23,945	$	23,077

Number of outstanding shares at end of period (000)	586,897		623,868

U.S. GAAP book value per common share	$	38.63	$	31.97	20.8	%
Less:
Unrealized foreign currency translation gains (losses) per common share	(7.64)		(7.01)
Unrealized gains (losses) on securities and derivatives per common share	(0.73)		1.77
Effect of changes in discount rate assumptions per common share	(1.48)		(6.53)
Pension liability adjustment per common share	0.03		(0.25)
Total AOCI per common share	(9.81)		(12.03)
Adjusted book value per common share	$	48.44	$	44.00	10.1	%
Add:
Unrealized foreign currency translation gains (losses) per common share	(7.64)		(7.01)
Adjusted book value including unrealized foreign currency translation gains (losses) per common share	$	40.80	$	36.99	10.3	%

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.


RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE
(EXCLUDING IMPACT OF FOREIGN CURRENCY)

THREE MONTHS ENDED SEPTEMBER 30,	2023		2022
U.S. GAAP ROE - Net earnings1	29.1	%	36.1	%
Impact of excluding unrealized foreign currency translation gains (losses)	(4.5)		(5.1)
Impact of excluding unrealized gains (losses) on securities and derivatives	0.8		2.7
Impact of excluding effect of changes in discount rate assumptions	(3.1)		(7.1)
Impact of excluding pension liability adjustment	—		(0.2)
Impact of excluding AOCI	(6.8)		(9.7)
U.S. GAAP ROE - less AOCI	22.3		26.4
Differences between adjusted earnings and net earnings2	(6.7)		(12.9)
Adjusted ROE - reported	15.6		13.5
Less: Impact of foreign currency3	(0.5)		N/A
Adjusted ROE, excluding impact of foreign currency	16.1		13.5

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.

1 U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

2 See separate reconciliation of net income to adjusted earnings.

3 Impact of foreign currency is calculated by restating all foreign currency components of the income statement to the weighted average foreign currency exchange rate for the comparable prior year period. The impact is the difference of the restated adjusted earnings compared to reported adjusted earnings. For comparative purposes, only current period income is restated using the weighted average prior period exchange rate, which eliminates the foreign currency impact for the current period. This allows for equal comparison of this financial measure.


RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE
(EXCLUDING IMPACT OF FOREIGN CURRENCY)

NINE MONTHS ENDED SEPTEMBER 30,	2023		2022
U.S. GAAP ROE - Net earnings1	27.4	%	30.4	%
Impact of excluding unrealized foreign currency translation gains (losses)	(4.0)		(3.7)
Impact of excluding unrealized gains (losses) on securities and derivatives	(0.6)		6.2
Impact of excluding effect of changes in discount rate assumptions	(1.5)		(11.5)
Impact of excluding pension liability adjustment	—		(0.2)
Impact of excluding AOCI	(6.1)		(9.2)
U.S. GAAP ROE - less AOCI	21.3		21.3
Differences between adjusted earnings and net earnings2	(6.7)		(7.2)
Adjusted ROE - reported	14.6		14.1
Less: Impact of foreign currency3	(0.5)		N/A
Adjusted ROE, excluding impact of foreign currency	15.0		14.1

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.

1 U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

2 See separate reconciliation of net income to adjusted earnings.


EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS1
(SELECTED PERCENTAGE CHANGES, UNAUDITED)

THREE MONTHS ENDED SEPTEMBER 30, 2023	Including Currency Changes		Excluding Currency Changes2
Net earned premiums3	(1.7)	%	2.4	%
Adjusted net investment income4	3.4		5.4
Total benefits and expenses	(6.7)		(3.0)
Adjusted earnings	20.3		24.0
Adjusted earnings per diluted share	27.8		31.9

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.

1Refer to previously defined adjusted earnings and adjusted earnings per diluted share.

2Amounts excluding currency changes were determined using the same foreign currency exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes.

3Net of reinsurance

4Refer to previously defined adjusted net investment income.


EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS1
(SELECTED PERCENTAGE CHANGES, UNAUDITED)

NINE MONTHS ENDED SEPTEMBER 30, 2023	Including Currency Changes		Excluding Currency Changes2
Net earned premiums3	(5.6)	%	(0.6)	%
Adjusted net investment income4	(1.2)		1.3
Total benefits and expenses	(8.0)		(3.2)
Adjusted earnings	7.3		10.9
Adjusted earnings per diluted share	14.3		18.2

All relevant prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration

insurance contracts.

1Refer to previously defined adjusted earnings and adjusted earnings per diluted share.

3Net of reinsurance

4Refer to previously defined adjusted net investment income.

FORWARD-LOOKING INFORMATION

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. The company desires to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as “expect,” “anticipate,” “believe,” “goal,” “objective,” “may,” “should,” “estimate,” “intends,” “projects,” “will,” “assumes,” “potential,” “target,” "outlook" or similar words as well as specific projections of future results, generally qualify as forward-looking. Aflac undertakes no obligation to update such forward-looking statements.

The company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:

•difficult conditions in global capital markets and the economy, including inflation and the continued effects caused by COVID-19

•defaults and credit downgrades of investments

•global fluctuations in interest rates and exposure to significant interest rate risk

•concentration of business in Japan

•limited availability of acceptable yen-denominated investments

•foreign currency fluctuations in the yen/dollar exchange rate

•differing interpretations applied to investment valuations

•significant valuation judgments in determination of expected credit losses recorded on the Company's investments

•decreases in the Company's financial strength or debt ratings

•decline in creditworthiness of other financial institutions

•concentration of the Company's investments in any particular single-issuer or sector

•major public health issues, including COVID-19 and any resulting or coincidental economic effects, on the Company's business and financial results

•the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners

•deviations in actual experience from pricing and reserving assumptions

•ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives

•interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security,

confidentiality or privacy of sensitive data residing on such systems

•subsidiaries' ability to pay dividends to the Parent Company

•inherent limitations to risk management policies and procedures

•operational risks of third party vendors

•tax rates applicable to the Company may change

•failure to comply with restrictions on policyholder privacy and information security

•extensive regulation and changes in law or regulation by governmental authorities

•competitive environment and ability to anticipate and respond to market trends

•catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics (such as COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events

•ability to protect the Aflac brand and the Company's reputation

•ability to effectively manage key executive succession

•changes in accounting standards

•level and outcome of litigation

•allegations or determinations of worker misclassification in the United States

Analyst and investor contact - David A. Young, 706.596.3264; 800.235.2667 or dyoung@aflac.com

Media contact - Ines Gutzmer, 762.207.7601 or igutzmer@aflac.com

EX-99.2 3 afl93023-fabdocument.htm EX-99.2 Document

FINAL 11/1/2023

Financial Supplement

Third Quarter 2023

This document is a statistical supplement to Aflac’s quarterly earnings release. Throughout the presentation, amounts presented may not foot due to rounding. As you review the supplement, please note the non-U.S. GAAP financial measures and definitions found at the back of this document.

The Company adopted the Financial Accounting Standards Board’s Accounting Standard Update 2018-12 Financial Services - Insurance: Targeted Improvements to the Accounting for Long-Duration Contracts, as clarified and amended by (i) ASU 2019-09 Financial Services - Insurance: Effective Date, and (ii) ASU 2020-11 Financial Services - Insurance: Effective Date and Early Application (collectively, “LDTI”) as of January 1, 2023. The amended guidance is applied as of the beginning of the earliest period presented in the Company’s quarterly and annual financial statements, which results in a January 1, 2021 Transition Date. In conjunction with the adoption of LDTI, the Company changed its practice of recording the change in the deferred profit liability (DPL) on products with limited-payment features from the benefits and claims, net line item to the net earned premiums line item in the consolidated statement of earnings. This change in presentation has no impact on net earnings. All quarterly and annual amounts for 2021 and 2022 presented herein reflect these changes for LDTI and DPL.


			Aflac Incorporated															Page
			Share Data															2
			Summary of Adjusted Results by Business Segment															3
			Statements of Earnings															4
			Analysis of Net Earnings and Net Earnings Per Share															5
			Balance Sheets															6
			Quarterly Financial Results															7
			Quarterly Book Value Per Share															8
			Return on Equity															9
			Adjusted Earnings Per Share Excluding Current Period Foreign Currency Impact															10
			Investment Results															11,12,13
			Long-Term Debt Data															14
			Ratings															15

			Aflac U.S.
			Statement of Pretax Adjusted Earnings															16
			Balance Sheets															17
			Quarterly Pretax Adjusted Earnings															18
			Operating Ratios															19
			Sales															20,21

			Aflac Japan
			Statement of Pretax Adjusted Earnings															22,23
			Balance Sheets															24,25
			Quarterly Pretax Adjusted Earnings															26
			Operating Ratios															27
			Sales															28,29,30
			Yen/Dollar Exchange Rates															31

			Corporate and Other
			Statement of Pretax Adjusted Earnings															32

			Non-U.S. GAAP Financial Measures															33

For more information, contact:

David Young

Phone. 706.596.3264

Aflacir@aflac.com

investors.aflac.com


Aflac Incorporated and Subsidiaries

	Share Data
	(In Thousands)


			Beginning	Shares Issued		Shares Purchased		Ending	QTD Weighted Avg. Shares			YTD Weighted Avg. Shares
			Shares	Stk. Bon.	Stk. Opt.	Treas.	Misc.	Shares	Avg.	Dilutive	Avg.	Avg.	Dilutive	Avg.
		Period	Outstanding	& DRP	& Misc.	Shares	Purch.(1)	Outstanding	Shares	Shares	Diluted	Shares	Shares	Diluted

	2021	1	692,454	387	1,684	13,440	378	680,707	688,938	3,002	691,940	688,938	3,002	691,940
		2	680,707	330	130	9,174	3	671,990	678,050	2,871	680,921	683,464	2,936	686,400
		3	671,990	250	188	9,572	39	662,817	668,762	3,163	671,925	678,509	3,012	681,521
		4	662,817	249	224	11,140	18	652,132	659,100	3,412	662,512	673,617	3,112	676,729

	2022	1	652,132	259	1,308	8,007	343	645,349	649,753	3,074	652,827	649,753	3,074	652,827
		2	645,349	269	101	11,185	8	634,526	640,707	2,536	643,243	645,205	2,805	648,010
		3	634,526	258	144	11,057	3	623,868	629,350	2,597	631,946	639,862	2,735	642,597
		4	623,868	222	120	8,938	16	615,256	619,845	3,149	622,994	634,816	2,839	637,655

	2023	1	615,256	239	1,152	10,348	347	605,952	611,205	2,745	613,950	611,205	2,745	613,950
		2	605,952	259	225	10,461	6	595,969	600,742	2,187	602,929	605,945	2,466	608,411
		3	595,969	210	115	9,390	7	586,897	591,246	2,350	593,596	600,992	2,427	603,419

(1) Includes previously owned shares used to purchase options (swapped shares) and/or shares purchased for deferred compensation program


Aflac Incorporated and Subsidiaries

	Summary of Adjusted Results by Business Segment
	(In Millions, except per-share data and where noted)

		Years Ended December 31,															3 Months Ended September 30,							9 Months Ended September 30,
																							%							%
		2018			2019			2020			2021			2022			2022			2023			Change	2022			2023			Change

	Aflac Japan	$	3,208		$	3,261		$	3,263		$	3,755		$	3,281		$	817		$	869		6.4	$	2,560		$	2,479		(3.2)
	Aflac U.S.		1,285			1,272			1,268			1,356			1,359			345			478		38.6		1,020			1,199		17.5
	Corporate and other (1)		(139)			(72)			(115)			(293)			(218)			(56)			(49)				(173)			(107)
	Pretax adjusted earnings		4,354			4,461			4,416			4,819			4,422			1,106			1,298		17.4		3,407			3,571		4.8
	Income taxes (1)		1,129			1,147			864			893			808			196			203		3.6		610			570		(6.6)
	Adjusted earnings (2)		3,226			3,314			3,552			3,925			3,614			910			1,095		20.3		2,797			3,001		7.3

	Reconciling items:
	Adjusted net investment gains (losses)		(297)			(15)			(229)			462			447			222			504				923			1,363
	Other and non-recurring income (loss) (3)		(75)			(1)			(28)			(73)			1			1			3				1			38
	Income tax benefit (expense) on items excluded from adjusted earnings (4)		83			3			72			(83)			357			648			(33)				501			(12)
	Tax reform adjustment (5)		(18)			4			—			—			—			—			—				—			—
	Tax valuation allowance release (6)		—			—			1,411			—			—			—			—				—			—
	Net earnings	$	2,920		$	3,304		$	4,778		$	4,231		$	4,418		$	1,781		$	1,569		(11.9)	$	4,222		$	4,391		4.0

	Effective Tax rate		26.7	%		25.7	%		(14.9)	%		18.7	%		9.3	%		(34.0)	%		13.1	%			2.5	%		11.7	%

	Earnings per share of common stock:
	Net earnings (basic)	$	3.79		$	4.45		$	6.69		$	6.28		$	6.96		$	2.83		$	2.65		(6.4)	$	6.60		$	7.31		10.8
	Net earnings (diluted)		3.77			4.43			6.67			6.25			6.93			2.82			2.64		(6.4)		6.57			7.28		10.8

	Adjusted earnings (basic) (2)	$	4.20		$	4.46		$	4.98		$	5.83		$	5.69		$	1.45		$	1.85		27.6	$	4.37		$	4.99		14.2
	Adjusted earnings (diluted) (2)		4.16			4.44			4.96			5.80			5.67			1.44			1.84		27.8		4.35			4.97		14.3

	(1) The change in value of federal historic rehabilitation and solar investments in partnerships of $64 and $19 for the three-month periods and $169 and $61 for the nine-month periods ended September 30, 2023, and 2022, respectively, is included as a reduction to net investment income. Tax credits on these investments of $63 and $19 for the three-month period and $171 and $63 for the nine-month periods ended September 30, 2023, and 2022, respectively, have been recorded as an income tax benefit in the consolidated statement of earnings.
	(2) See non-U.S. GAAP financial measures for definition of adjusted earnings.
	(3) Foreign currency gains and losses for all periods have been reclassified from Other and non-recurring income (loss) to Net investment gains and losses.
	(4) Primarily reflects release of $695 in deferred taxes in 2022
	(5) The impact of Tax Reform was adjusted in 2018 for return-to-provision adjustments, various amended returns filed by the Company, and final true-ups of deferred tax liabilities. Further impacts were recorded in 2019 as a result of additional guidance released by the IRS.
	(6) Tax benefit recognized in 2020 represents the release of valuation allowances on deferred tax benefits related to foreign tax credits.


Aflac Incorporated and Subsidiaries

	Consolidated Statements of Earnings - U.S. GAAP
	(In Millions, except per-share data)

			Years Ended December 31,										3 Months Ended September 30,					9 Months Ended September 30,
																	%					%
			2018		2019		2020		2021		2022		2022		2023		Change	2022		2023		Change
	Revenues:
		Net earned premiums
		Gross premiums	$	19,018	$	19,122	$	18,955	$	17,305	$	15,025	$	3,565	$	3,524		$	11,472	$	10,885
		Assumed (ceded)		(341)		(342)		(333)		(210)		(124)		(30)		(48)			(93)		(148)
		Total net earned premiums		18,677		18,780		18,622		17,095		14,901		3,535		3,476	(1.7)		11,379		10,737	(5.6)
		Net investment income		3,442		3,578		3,638		3,818		3,656		920		1,004	9.1		2,760		2,946	6.7
		Net investment gains (losses) (1)		(430)		(135)		(270)		468		363		199		423			885		1,101
		Other income (1)		69		84		157		173		220		50		47			168		139
		Total revenues		21,758		22,307		22,147		21,554		19,140		4,704		4,950	5.2		15,192		14,923	(1.8)

	Benefits and Claims:
		Benefits and claims, net
		Incurred claims -direct		9,121		9,279		9,364		8,949		8,271		2,112		1,871			6,445		6,034
		Incurred claims -assumed (ceded)		(421)		(372)		(296)		(147)		(108)		(47)		(33)			(89)		(114)
		Increase in FPB (2)-direct		3,167		2,952		2,707		1,819		888		63		231			575		499
		Increase in FPB (2)-assumed (ceded)		133		83		21		3		51		41		(4)			54		1
		Total net benefits and claims, excluding reserve remeasurement		N/A		N/A		N/A		10,623		9,102		2,169		2,065			6,985		6,420
		Reserve remeasurement (gain) loss		N/A		N/A		N/A		(147)		(215)		(93)		(205)			(152)		(312)
		Total net benefits and claims		12,000		11,942		11,796		10,476		8,887		2,076		1,860	(10.4)		6,833		6,108	(10.6)
		Acquisition and operating expenses:
		Amortization of DAC (3)		1,245		1,282		1,214		835		792		194		201			598		608
		Insurance commissions		1,320		1,321		1,316		1,256		1,117		267		250			846		797
		Insurance expenses		2,988		3,089		3,420		3,541		3,249		779		785			2,413		2,290
		Interest expense		222		228		242		238		226		59		49			171		148

		Total acquisition and operating expenses		5,775		5,920		6,192		5,870		5,384		1,299		1,285	(1.1)		4,028		3,843	(4.6)
		Total benefits and expenses		17,775		17,862		17,988		16,346		14,271		3,375		3,145	(6.8)		10,861		9,951	(8.4)

		Pretax earnings		3,983		4,445		4,159		5,208		4,869		1,329		1,805			4,331		4,972

		Income tax expense (benefit) (4)		1,063		1,141		(619)		977		451		(452)		236			109		581

		Net earnings	$	2,920	$	3,304	$	4,778	$	4,231	$	4,418	$	1,781	$	1,569	(11.9)	$	4,222	$	4,391	4.0

		(1) Foreign currency gains and losses for all periods have been reclassified from Other income to Net investment gains and losses for consistency with current period presentation.
		(2) Future policy benefits
		(3) Deferred acquisition costs
		(4) Primarily reflects release of $695 in deferred taxes in 2022


Aflac Incorporated and Subsidiaries

Analysis of Net Earnings and Net Earnings Per Diluted Share
(In Millions, except for per-share data)


									Other and	Foreign
				Net	Other and Non-	Foreign	Net	Net	Non-Recurring	Currency
			Net	Investment	Recurring	Currency	Earnings	Investment	Items	Impact
		Period	Earnings	Gains (Losses) (1)	Items (1)(3)(4)	Impact (2)	Per Share	Gains (Losses) (1)	Per Share (1)(3)(4)	Per Share (2)

		2018	2,920	(230)	(76)	28	3.77	(.30)	(.09)	.04
		2019	3,304	(13)	3	15	4.43	(.02)	.01	.02
		2020	4,778	(181)	1,407	31	6.67	(.25)	1.96	.04
		2021	4,231	365	(59)	(42)	6.25	.54	(.09)	(.06)
		2022	4,418	803	1	(262)	6.93	1.26	—	(.41)


	2021	1	1,224	240	(5)	5	1.77	.35	(.01)	.01
		2	1,027	67	(42)	(6)	1.51	.10	(.06)	(.01)
		3	915	(136)	(7)	(12)	1.36	(.20)	(.01)	(.02)
		4	1,065	194	(5)	(29)	1.61	.29	(.01)	(.04)

	2022	1	1,047	106	(1)	(35)	1.60	.16	—	(.05)
		2	1,394	448	—	(59)	2.17	.70	—	(.09)
		3	1,781	871	1	(97)	2.82	1.38	—	(.15)
		4	196	(621)	—	(70)	.31	(1.00)	—	(.11)

	2023	1	1,188	235	—	(41)	1.94	.38	—	(.07)
		2	1,634	653	28	(25)	2.71	1.08	.05	(.04)
		3	1,569	472	2	(33)	2.64	.80	—	(.06)





	(1) Items are presented net of tax.
	(2) See non-U.S. GAAP financial measures for definition of adjusted earnings excluding current period foreign currency impact
	(3) Foreign currency gains and losses and amortized hedge costs/income for all periods have been reclassified from Other income to Net investment gains and losses for consistency with current period presentation.
	(4 )Tax benefit recognized in the third quarter of 2020 represents the release of valuation allowances on deferred tax benefits related to foreign tax credits.


Aflac Incorporated and Subsidiaries
	Consolidated Balance Sheets
	(In Millions, except per-share data)

				December 31,										September 30,
	Assets:			2018		2019		2020		2021		2022			2022			2023

	Investments and cash:
		Securities available for sale:
		Fixed maturity securities available for sale, at fair value		$	78,429	$	86,950	$	101,286	$	94,206	$	71,936			$	70,026		$	66,369
		Fixed maturity securities available for sale - consolidated variable interest entities, at fair value			4,466		4,312		4,596		4,490		3,805				3,617			3,432
		Fixed maturity securities held to maturity, at amortized cost, net of allowance for credit losses			30,318		30,085		24,464		22,000		19,056				17,466			16,899
		Equity securities, at fair value			987		802		1,283		1,603		1,091				1,064			990
		Commercial mortgage and other loans, net of allowance for credit losses			6,919		9,569		10,554		11,786		13,496				13,459			12,873
		Other investments			787		1,477		2,429		3,842		4,070				4,186			5,241
		Cash and cash equivalents			4,337		4,896		5,141		5,051		3,943				4,710			5,502
			Total investments and cash		126,243		138,091		149,753		142,978		117,397				114,528			111,306

	Receivables, net of allowance for credit losses (1)				844		816		778		672		647				629			712
	Accrued investment income				773		772		780		737		745				684			687
	Deferred policy acquisition costs				9,875		10,128		10,441		9,848		9,239				8,666			8,771
	Property and equipment, net				443		581		601		538		530				488			445
	Other assets, net of allowance for credit losses (1)(2)				2,228		2,380		2,733		3,377		3,180				3,720			3,190
			Total assets	$	140,406	$	152,768	$	165,086	$	158,150	$	131,738			$	128,715		$	125,111

	Liabilities and Shareholders' Equity:
	Liabilities:
		Total policy liabilities		$	103,188	$	106,554	$	114,391	$	126,331	$	96,910			$	92,586		$	86,028
		Notes payable			5,778		6,569		7,899		7,956		7,442				7,518			6,961
		Income taxes, primarily deferred			4,020		5,370		4,661		30		698				764			869
		Other liabilities			3,958		5,316		4,576		6,802		6,548				7,901			8,584
			Total liabilities		116,944		123,809		131,527		141,119		111,598				108,769			102,442
	Shareholders' equity:
		Common stock			135		135		135		135		135				135			136
		Additional paid-in capital			2,177		2,313		2,410		2,529		2,641				2,615			2,729
		Retained earnings			31,788		34,291		37,984		40,963		44,367				44,680			48,257
		Accumulated other comprehensive income (loss):
			Unrealized foreign currency translation gains (losses)		(1,847)		(1,623)		(1,109)		(1,985)		(3,564)				(4,374)			(4,484)
			Unrealized gains (losses) on fixed maturity securities		4,234		8,548		10,361		9,602		(702)				1,131			(403)
			Unrealized gains (losses) on derivatives		(24)		(33)		(34)		(30)		(27)				(29)			(24)
			Effect on change in discount rate assumption(s)		N/A		N/A		N/A		(15,832)		(2,100)				(4,075)			(866)
			Pension liability adjustment		(212)		(277)		(284)		(166)		(36)				(158)			17
		Treasury stock			(12,789)		(14,395)		(15,904)		(18,185)		(20,574)				(19,979)			(22,693)
			Total shareholders' equity		23,462		28,959		33,559		17,031		20,140				19,946			22,669
			Total liabilities & shareholders' equity	$	140,406	$	152,768	$	165,086	$	158,150	$	131,738			$	128,715		$	125,111

(1) Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on net earnings or total shareholders' equity.

(2) Includes goodwill of $269 million in 2023, $265 million in 2022, $268 in 2021, $269 in 2020, $140 million in 2019 and $67 million in 2018


Aflac Incorporated and Subsidiaries

Quarterly Financial Results
(Dollars In Millions, except per-share data)

							Total
			Net	Net		Benefits	Acquisitions	Total			Net EPS		Adj. EPS (1)
			Earned	Inv.	Total	&	&	Pretax	Net	Adjusted
		Period	Premiums	Income	Revenues	Claims, Net	Adj. Exp.	Earn.	Earn.	Earn. (1)	Basic	Dil.	Basic	Dil.

		2018	18,677	3,442	21,758	12,000	5,775	3,983	2,920	3,226	3.79	3.77	4.20	4.16
		2019	18,780	3,578	22,307	11,942	5,920	4,445	3,304	3,314	4.45	4.43	4.46	4.44
		2020	18,622	3,638	22,147	11,796	6,192	4,159	4,778	3,552	6.69	6.67	4.98	4.96
		2021	17,095	3,818	21,554	10,476	5,870	5,208	4,231	3,925	6.28	6.25	5.83	5.80
		2022	14,901	3,656	19,140	8,887	5,384	4,869	4,418	3,614	6.96	6.93	5.69	5.67
		2023	10,737	2,946	14,923	6,108	3,843	4,972	4,391	3,001	7.31	7.28	4.99	4.97

	2021	1	4,434	925	5,710	2,771	1,420	1,519	1,224	989	1.78	1.77	1.44	1.43
		2	4,301	993	5,424	2,672	1,474	1,277	1,027	1,002	1.51	1.51	1.48	1.47
		3	4,229	991	5,098	2,503	1,450	1,146	915	1,058	1.37	1.36	1.58	1.57
		4	4,132	910	5,322	2,529	1,527	1,266	1,065	875	1.62	1.61	1.33	1.32

	2022	1	4,079	903	5,173	2,483	1,396	1,294	1,047	942	1.61	1.60	1.45	1.44
		2	3,764	937	5,315	2,274	1,333	1,708	1,394	945	2.18	2.17	1.47	1.47
		3	3,535	920	4,704	2,076	1,299	1,329	1,781	910	2.83	2.82	1.45	1.44
		4	3,523	896	3,948	2,054	1,356	538	196	817	.32	.31	1.32	1.31

	2023	1	3,688	943	4,800	2,150	1,308	1,342	1,188	953	1.94	1.94	1.56	1.55
		2	3,573	999	5,172	2,098	1,249	1,825	1,634	954	2.72	2.71	1.59	1.58
		3	3,476	1,004	4,950	1,860	1,285	1,805	1,569	1,095	2.65	2.64	1.85	1.84

(1) See non-U.S. GAAP financial measures for definition of adjusted earnings.


Aflac Incorporated and Subsidiaries

Quarterly Book Value Per Share
(Dollars In Millions, except per-share data)

								Adjusted BV
							Adjusted BV	Per Share Incl
			Equity	AOCI		Adjusted BV	Per Share Incl	Foreign Currency
			BV Per	BV Per	Adjusted BV	Per Share	Foreign Currency	Translation G/(L)
		Period	Share	Share	Per Share (1)	% Change	Translation G/(L)(1)	% Change

		2018	31.06	2.85	28.22	7.1%	25.77	6.9%
		2019	39.84	9.10	30.74	8.9%	28.51	10.6%
		2020	48.46	12.90	35.56	15.7%	33.96	19.1%
		2021	26.12	(12.90)	39.01	9.7%	35.97	5.9%
		2022	32.73	(10.45)	43.18	10.7%	37.39	3.9%


	2021	1	22.98	(13.60)	36.59	18.3%	34.15	18.7%
		2	24.39	(13.18)	37.57	18.3%	35.12	18.2%
		3	25.19	(13.20)	38.39	10.0%	35.77	8.1%
		4	26.12	(12.90)	39.01	9.7%	35.97	5.9%

	2022	1	27.21	(13.09)	40.31	10.1%	36.53	7.0%
		2	30.82	(11.00)	41.82	11.3%	36.75	4.6%
		3	31.97	(12.03)	44.00	14.6%	36.99	3.4%
		4	32.73	(10.45)	43.18	10.7%	37.39	3.9%

	2023	1	32.65	(12.01)	44.66	10.8%	38.69	5.9%
		2	34.30	(12.31)	46.61	11.5%	39.48	7.4%
		3	38.63	(9.81)	48.44	10.1%	40.80	10.3%

(1) See non-U.S. GAAP financial measures for definition of adjusted book value and adjusted book value including unrealized foreign currency translation gains and losses.


Aflac Incorporated and Subsidiaries

	Return on Equity


				Year Ended December 31,										3 Months Ended September 30,						9 Months Ended September 30,

				2018		2019		2020		2021 (4)		2022		2022			2023				2022			2023
	U.S. GAAP ROE (1) - Net earnings			12.2	%	12.6	%	15.3	%	26.7	%	23.8	%		36.1	%		29.1	%			30.4	%		27.4	%

		Impact of excluding unrealized foreign currency translation gains (losses)		(1.0)		(1.0)		(0.9)		(1.7)		(2.5)			(5.1)			(4.5)				(3.7)			(4.0)
		Impact of excluding unrealized gains (losses) on securities and derivatives		3.0		3.6		6.2		10.7		4.1			2.7			0.8				6.2			(0.6)
		Impact of excluding effect on change in discount rate assumptions		N/A		N/A		N/A		(18.5)		(8.2)			(7.1)			(3.1)				(11.5)			(1.5)
		Impact of excluding pension liability adjustment		(0.1)		(0.1)		(0.2)		(0.2)		(0.1)			(0.2)			—				(0.2)			—

			Impact of excluding AOCI	1.8		2.5		5.1		(9.7)		(6.8)			(9.7)			(6.8)				(9.2)			(6.1)

	U.S. GAAP ROE - less AOCI			13.9		15.1		20.3		17.0		17.0			26.4			22.3				21.3			21.3

	Differences between adjusted earnings and net earnings (2)			1.5		0.0		(5.2)		(1.2)		(3.1)			(12.9)			(6.7)				(7.2)			(6.7)

	Adjusted ROE - reported (3)			15.4		15.2		15.1		15.8		13.9			13.5			15.6				14.1			14.6
















		(1)	U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.
		(2)	See separate reconciliation of net income to adjusted earnings.




		(3)	See non-U.S. GAAP financial measures for definition of adjusted return on equity
		(4)	Return on equity calculations for 2021 use beginning retained earnings and accumulated other comprehensive income adjusted for the adoption of LDTI.


Aflac Incorporated and Subsidiaries

	Adjusted Earnings Per Share Excluding Current Period Foreign Currency Impact (1)
		(Diluted Basis)

												Change
								QTD	YTD	Excluding		Excluding
								Foreign	Foreign	Foreign		Foreign
				Adjusted				Currency	Currency	Currency		Currency
			Period	EPS(1)		Growth		Impact(1)	Impact(1)	Impact(1)		Impact

			2018	$	4.16	22.4	%	N/A	.04	$	4.13	21.5	%
			2019	$	4.44	6.7	%	N/A	.02	$	4.42	6.3	%
			2020	$	4.96	11.7	%	N/A	.04	$	4.92	10.8	%
			2021	$	5.80	16.9	%	N/A	(.06)	$	5.86	18.1	%
			2022	$	5.67	(2.2)	%	N/A	(.41)	$	6.08	4.8	%


		2021	1	$	1.43	18.2	%	.01	.01	$	1.42	17.4	%
			2	1.47		14.8		(.01)	—	1.48		15.6
			3	1.57		12.9		(.02)	(.02)	1.59		14.4
			4	1.32		23.4		(.04)	(.06)	1.36		27.1
				$	5.80	16.9	%			$	5.86	18.1	%

		2022	1	$	1.44	.7	%	(.05)	(.05)	$	1.50	4.9	%
			2	1.47		—		(.09)	(.15)	1.56		6.1
			3	1.44		(8.3)		(.15)	(.30)	1.59		1.3
			4	1.31		(.8)		(.11)	(.41)	1.43		8.3
				$	5.67	(2.2)	%			$	6.08	4.8	%

		2023	1	$	1.55	7.6	%	(.07)	(.07)	$	1.62	12.5	%
			2	1.58		7.5		(.04)	(.11)	1.62		10.2
			3	1.84		27.8		(.06)	(.17)	1.90		31.9

				$	4.97	14.3	%			$	5.14	18.2	%


		(1) See non-U.S.GAAP financial measures for definition of adjusted earnings and adjusted earnings excluding current period foreign currency impact


Aflac Incorporated and Subsidiaries

	Composition of Invested Assets
	(In Millions)

			December 31,															September 30,
			2018			2019			2020			2021			2022					2022				2023

	Fixed Maturity Securities(1)		$	107,174		$	109,456		$	116,056		$	107,369		$	94,525						$	88,501			$	86,060

	Commercial mortgage and other loans, net of allowance for credit losses (1)
	Transitional Real Estate (floating rate)			4,378			5,450			5,231			5,246			6,455							6,447				6,439
	Middle Market Loans (floating rate)			1,478			2,412			3,635			4,601			5,028							4,995				4,712
	Commercial Mortgage Loans			1,063			1,707			1,688			1,874			2,013							2,017				1,722
		Total Commercial mortgage and other loans, net of allowance for credit losses(1)		6,919			9,569			10,554			11,721			13,496							13,459				12,873

	Equity Securities, at FV through net earnings			987			802			1,283			1,603			1,091							1,064				990

	Alternatives(2)			370			551			919			1,703			2,107							2,004				2,498

	Total Portfolio		$	115,450		$	120,378		$	128,812		$	122,396		$	111,219						$	105,028			$	102,421

	Unrealized Gains (Losses) on Invested Assets
	(In Millions)

			December 31,																September 30,
			2018			2019			2020			2021			2022						2022				2023
	Fixed Maturity Securities
	Available For Sale - Gross Gains		$	7,733		$	12,266		$	14,771		$	13,566		$	4,800						$	6,162			$	5,061
	Available For Sale - Gross Losses			(1,694)			(375)			(481)			(239)			(4,528)							(3,554)				(4,421)
	Total Available For Sale			6,039			11,891			14,290			13,327			272							2,608				640

	Held to Maturity - Gross Gains			6,470			7,519			5,935			4,869			2,154							2,619				1,561
	Held to Maturity - Gross Losses			(66)			(10)			—			—			—							—				—
	Total Held to Maturity		$	6,404		$	7,509		$	5,935		$	4,869		$	2,154						$	2,619			$	1,561

		Credit Ratings on Fixed Maturities
		(At Amortized Cost)

			December 31,															September 30,
		Credit Rating	2018			2019			2020			2021			2022					2022				2023
		AAA		1.0	%		1.1	%		1.0	%		1.0	%		1.6	%						1.6	%			1.5	%
		AA		3.9			4.3			4.5			5.1			5.2							5.4				5.7
		A		67.9			68.6			69.3			68.9			68.0							67.6				68.0
		BBB		23.2			23.1			21.9			22.5			23.0							23.0				22.8
		BB or Lower		4.0			2.9			3.3			2.5			2.2							2.4				2.0
				100.0	%		100.0	%		100.0	%		100.0	%		100.0	%						100.0	%			100.0	%

	(1) Presented at amortized cost, net of reserves beginning in 2020
	(2) Presented at carrying value; includes asset classes such as private equity and real estate funds managed by Global Investments; excludes Corporate driven activity, policy loans, short-term investments, real estate owned assets and FHLB equity balances


Aflac Incorporated and Subsidiaries
			Supplemental Investment Data by Segment


																				3 Months Ended							9 Months Ended
				December 31,															September 30,							September 30,
				2018			2019			2020			2021			2022				2022			2023				2022			2023

	Aflac Japan:
		Invested assets (in millions)(1)		¥	11,442,444		¥	11,784,586		¥	11,936,087		¥	12,405,531		¥	12,617,181			¥	12,920,895		¥	12,945,618			¥	12,920,895		¥	12,945,618
		Return on average invested assets(2)		2.33		%	2.33		%	2.38		%	2.72		%	2.78		%		2.87		%	3.07		%		2.79		%	2.80		%
		Portfolio book yield at end of period(3)		2.61		%	2.64		%	2.59		%	2.60		%	3.06		%		2.91		%	3.19		%		2.91		%	3.19		%
		Total purchases for period (in millions)(3)		¥	1,298,376		¥	1,003,885		¥	714,124		¥	952,038		¥	716,964			¥	142,844		¥	70,531			¥	637,747		¥	317,355
		New money yield(3)(4)		3.06		%	3.83		%	3.75		%	3.50		%	4.48		%		5.73		%	4.28		%		4.16		%	4.84		%

	Aflac U.S.:
		Invested assets (in millions)(1)		$	13,798		$	14,036		$	14,848		$	15,841		$	16,772			$	16,472		$	16,861			$	16,472		$	16,861
		Return on average invested assets(2)		5.16		%	5.70		%	4.90		%	4.87		%	4.72		%		4.57		%	5.04		%		4.74		%	4.84		%
		Portfolio book yield at end of period(3)		5.55		%	5.40		%	5.18		%	4.94		%	5.39		%		5.21		%	5.52		%		5.21		%	5.52		%
		Total purchases for period (in millions)(3)		$	2,155		$	1,835		$	1,050		$	2,130		$	1,701			$	427		$	217			$	1,394		$	748
		New money yield(3)(4)		4.55		%	4.51		%	3.04		%	3.41		%	5.16		%		6.24		%	7.21		%		4.90		%	7.38		%

	Hedge Costs/Income Metrics (5)(6)

																				3 Months Ended							9 Months Ended
				December 31,															September 30,							September 30,
				2018			2019			2020			2021			2022				2022			2023				2022			2023
	Aflac Japan:
			FX hedged notional at end of period (in billions) - forwards (7)	$	9.9		$	8.8		$	6.0		$	6.4		$	4.1			$	4.1		$	—			$	4.1		$	—
			FX hedged notional at end of period (in billions) - put options	—			9.2			13.1			11.6			13.5				13.5			24.4				13.5			24.4
			Amortized hedge costs for period (in millions)	(236)			(257)			(206)			(76)			(112)				(28)			(26)				(84)			(148)
	Corporate and Other (Parent Company):
			FX hedged notional at end of period (in billions) - forwards (7)	$	2.5		$	4.9		$	5.0		$	5.0		$	5.0			$	5.0		$	2.4			$	5.0		$	2.4
			FX hedged notional at end of period (in billions) - put options	—			2.0			2.0			1.9			2.6				1.7			0.9				1.7			0.9
			Amortized hedge income (costs) for period (in millions)	36			89			97			57			68				19			25				44			92

	(1) Invested assets, including cash and short term investments, are stated at amortized cost; except for equities, which are at fair value.
	(2) Net of investment expenses and amortized hedge costs, year-to-date number reflected on a quarterly average basis
	(3) Includes fixed maturity securities, commercial mortgage and other loans, equity securities, and excludes alternative investments in limited partnerships, and any impacts from hedging activities
	(4) Reported on a gross yield basis; excludes investment expenses, external management fees, and amortized hedge costs
	(5) See non-U.S. GAAP financial measures for definition of amortized hedge costs/income. Further, the metrics in this table are split to show the hedging of the market value of a portion of the USD investments in Japan Segment’s "USD Program" in the "Japan Segment Portfolio Allocation by Currency" table on page 13 of this supplement as well as the corporate hedging activities at Aflac Incorporated
	(6) Aflac Japan and the Parent Company utilize foreign currency forwards and options to hedge foreign currency exchange rate risk. The hedge cost/income on the table above reflects our FX forward protection of the hedged USD portfolio, and hedge costs on one sided options used as caps, and on tail-risk put options.
	(7) Notional is reported net of any offsetting positions within Aflac Japan or the Parent Company, respectively.


Aflac Incorporated and Subsidiaries


		Japan Segment Portfolio Allocation by Currency (1)
		(Dollars In Millions, U.S. GAAP Basis)

			December 31, 2022				September 30, 2023
			Amortized Cost (3)		Fair Value		Amortized Cost (3)		Fair Value
	JGB		$	42,618	$	44,178	$	37,858	$	38,498
	Other		20,930		21,277		18,365		18,976
	Total yen denominated		63,548		65,455		56,223		57,474

	USD Program		27,212		27,885		24,176		25,730
	Other		2,209		2,795		1,974		2,670
	US dollar denominated		29,421		30,680		26,150		28,400

	Total		$	92,969	$	96,135	$	82,373	$	85,874


		Distribution of Consolidated Fixed Maturities by Sector (2)
							September 30, 2023
	(In millions)						Amortized Cost (3)		% of Total
	Government and agencies						$	38,994	45.3		%
	Municipalities						2,412		2.8
	Mortgage- and asset-backed securities						2,847		3.3
	Public utilities						7,027		8.2
	Electric						5,724		6.7
	Natural Gas						771		.9
	Other						532		.6
	Sovereign and supranational						872		1.0
	Banks/financial institutions						8,257		9.5
	Banking						4,940		5.7
	Insurance						1,667		1.9
	Other						1,650		1.9
	Other corporate						25,651		29.9
	Basic Industry						2,220		2.6
	Capital Goods						3,162		3.7
	Communications						2,704		3.1
	Consumer Cyclical						1,954		2.3
	Consumer Non-Cyclical						5,836		6.8
	Energy						2,316		2.7
	Other						1,206		1.4
	Technology						3,442		4.0
	Transportation						2,811		3.3
	Total fixed maturity securities						$	86,060	100.0		%

	(1) The entire U.S. segment investment portfolio is U.S. dollar denominated.
	(2)In the first quarter of 2023, the Utility/Energy subsector was combined with the Natural Gas subsector to better reflect the risk characteristics of those issuers and align more closely with industry benchmarks.
	(3) Net of reserves


Aflac Incorporated and Subsidiaries

Long-Term Debt Data

Adjusted Leverage Ratios
(In Millions)

		December 31,															September 30,
			2018			2019			2020			2021			2022			2022		2023

	Notes payable	$	5,778		$	6,569		$	7,899		$	7,956		$	7,442		$	7,518	$	6,961
	50% of subordinated debentures and perpetual bonds		(268)			(408)			(432)			(389)			(337)			(309)		(299)
	Pre-funding of debt maturities		—			(348)			—			—			—			(448)		—
	Adjusted debt (1)		5,510			5,814			7,467			7,568			7,105			6,762		6,663

	Total Shareholders' Equity		23,462			28,959			33,559			17,031			20,140			19,946		22,669
	Accumulated other comprehensive (income) loss:
	Unrealized foreign currency translation (gains) losses		1,847			1,623			1,109			1,985			3,564			4,374		4,484
	Unrealized (gains) losses on fixed maturity securities		(4,234)			(8,548)			(10,361)			(9,602)			702			(1,131)		403
	Unrealized (gains) losses on derivatives		24			33			34			30			27			29		24
	Effect on change in discount rate assumptions		N/A			N/A			N/A			15,832			2,100			4,075		866
	Pension liability adjustment		212			277			284			166			36			158		(17)
	Adjusted book value (1)		21,311			22,344			24,625			25,442			26,569			27,451		28,429

	Adjusted capitalization ex-AOCI(1)(2)	$	27,089		$	28,565		$	32,524		$	33,398		$	34,011		$	34,521	$	35,390
	Adjusted debt to adjusted capitalization ex-AOCI		20.3	%		20.4	%		23.0	%		22.7	%		20.9	%		19.6		18.8	%

	Adjusted capitalization(1)(3)	$	25,030		$	26,665		$	31,131		$	31,247		$	30,411		$	29,989	$	30,923
	Adjusted debt to adjusted capitalization		22.0	%		21.8	%		24.0	%		24.2	%		23.4	%		22.5		21.5	%


Debt Maturities(4)
(In Millions)
September 30, 2023

		≤ 1 year		1 > 5 years		5 > 10 years		10 > 20 years		20 years +		Total

	Senior Notes	$	—	$	1,262	$	2,953	$	896	$	1,164	$	6,275
	Subordinated debt		—		—		—		—		602		602


	Total	$	—	$	1,262	$	2,953	$	896	$	1,766	$	6,877

(1) See non-U.S. GAAP financial measures for definition of: adjusted debt; adjusted book value; adjusted debt, including 50% of subordinated debentures and perpetual bonds; and adjusted book value, including unrealized foreign currency translation gains and losses and pension liability adjustment

(2) Adjusted capitalization ex-AOCI is the sum of adjusted debt, including 50% of subordinated debentures and perpetual bonds, plus adjusted book value

(3)Adjusted capitalization is sum of adjusted debt, including 50% of subordinated debentures and perpetual bonds, plus adjusted book value, including unrealized foreign currency translation gains and losses and pension liability adjustment

(4) Debt maturity amounts do not include discounts, premiums, deferred charges, or capital lease obligations.

Aflac Incorporated and Subsidiaries

Insurer Financial Strength Ratings

AM Best

Moody's

S&P

JCR

R&I

U.S. Operating Companies

Aflac of Columbus

A+

Aa3

A+

Aflac of New York

A+

Continental American Insurance Company

A+

Japan Operating Company

Aflac Life Insurance Japan Ltd.

A+

Aa3

A+

Bermuda Operating Company

Aflac Re Bermuda Ltd.

Issuer Credit Ratings

AM Best

Moody's

S&P

JCR

R&I

Aflac Incorporated

Long-term Senior Debt

A-

A+

Junior Subordinated Debt

Baa1

BBB

A-

Aflac of Columbus

Long-term Senior Debt

A+

Aflac Life Insurance Japan, Ltd.

Long-term Senior Debt

A+

Subordinated Bonds

AA-

The outlook for all ratings assigned by A.M. Best, S&P, Moody's, JCR and R&I is stable.


Aflac U.S.

	Statements of Pretax Adjusted Earnings
	(Before Management Fee)
	(In Millions)



			Years Ended December 31,										3 Months Ended September 30,					9 Months Ended September 30,
																	%					%
			2018		2019		2020		2021			2022		2022		2023	Change		2022		2023	Change

	Revenues:
		Net earned premiums
		Gross premiums	$	5,711	$	5,818	$	5,762	$	5,540	$	5,467	$	1,353	$	1,418		$	4,101	$	4,256
		Assumed (ceded)		(3)		(11)		(4)		73		103		22		1			81		16
		Total net earned premiums		5,708		5,808		5,758		5,613		5,570		1,375		1,419	3.2		4,182		4,272	2.2
		Adjusted net investment income		727		720		705		754		755		185		209	13.0		563		609	8.2
		Other income excl. realized foreign
		exchange gains (losses)		8		22		102		121		161		38		33			120		102

		Total adjusted revenues		6,443		6,550		6,565		6,489		6,486		1,598		1,661	3.9		4,865		4,983	2.4

	Benefits and claims:
		Benefits and claims, net
		Incurred claims -direct		2,560		2,611		2,498		2,183		2,245		563		602			1,719		1,796
		Incurred claims -assumed (ceded)		(4)		(5)		(1)		89		104		17		6			84		20
		Increase in FPB -direct		331		268		271		463		326		75		74			215		234
		Increase in FPB -assumed (ceded)		(1)		(2)		(3)		(11)		4		8		(1)			6		(3)
		Total benefits and claims, net, excluding reserve remeasurement		N/A		N/A		N/A		2,724		2,679		663		682			2,024		2,048
		Reserve remeasurement (gain) loss		N/A		N/A		N/A		(85)		(124)		(47)		(172)			(84)		(242)
		Total benefits and claims, net		2,887		2,871		2,765		2,639		2,555		616		510	(17.2)		1,940		1,805	(7.0)

	Adjusted expenses:
		Amortization of deferred policy
		acquisition costs		534		573		570		442		455		114		122	7.0		340		361	6.2
		Insurance commissions		585		590		576		550		553		135		138	2.2		411		420	2.2
		Insurance and other expenses		1,152		1,244		1,386		1,502		1,564		389		414	6.4		1,154		1,198	3.8
		Total adjusted expenses		2,271		2,407		2,532		2,494		2,573		638		674			1,905		1,979

		Total benefits and adjusted expenses		5,158		5,279		5,297		5,132		5,127		1,254		1,183	(5.7)		3,845		3,784	(1.6)

		Pretax adjusted earnings	$	1,285	$	1,272	$	1,268	$	1,356	$	1,359	$	345	$	478	38.6	$	1,020	$	1,199	17.5


Aflac U.S.

	Balance Sheets
	(In Millions)



			December 31,										September 30,

			2018		2019		2020		2021		2022			2022			2023
	Assets:

	Investments and cash		$	14,518	$	16,141	$	17,949	$	18,324	$	15,987			$	15.459		$	15,641
	Receivables, net of allowance for credit losses (1)			561		650		667		574		584				583			681
	Accrued investment income			178		174		172		169		184				174			181
	Deferred policy acquisition costs			3,491		3,544		3,450		3,366		3,463				3,401			3,530
	Other assets (1)			352		436		626		758		784				770			718

		Total assets	$	19,100	$	20,945	$	22,864	$	23,191	$	21,002			$	20,386		$	20,751


	Liabilities and Shareholders' Equity:

	Future policy benefits		$	9,137	$	9,404	$	9,674	$	14,212	$	10,870			$	10,553		$	10,319
	Policy and contract claims			1,727		1,779		2,010		151		200				201			246
	Other policy liabilities			116		111		126		119		117				113			111

	Deferred income taxes			(397)		51		235		(328)		(243)				(329)			(226)
	Other liabilities			1,577		1,803		2,016		2,010		2,080				2,087			1,845
	Shareholders' equity			6,939		7,796		8,803		7,027		7,978				7,761			8,457

		Total liabilities & shareholders' equity	$	19,100	$	20,945	$	22,864	$	23,191	$	21,002			$	20,386		$	20,751

(1) Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on

net earnings or total shareholders' equity.


Aflac U.S.

Quarterly Statements of Pretax Adjusted Earnings and Percentage Changes
(Restated to conform to current classifications)
(Dollars In Millions)
		Net				Total		Benefits					Total				Pretax
		Earned	%	Adjusted	%	Adjusted	%	&	%		%	Adjusted			%	Adjusted		%
	Period	Premiums	Change	NII	Change	Revenues	Change	Claims, Net	Change	Amort.	Change	Expenses			Change	Earn.		Change

	2018	5,708	2.6	727	.8	6,443	2.4	2,887	.1	534	6.4			2,271		5.2		1,285	3.2
	2019	5,808	1.8	720	(1.0)	6,550	1.7	2,871	(.6)	573	7.3			2,407		6.0		1,272	(1.0)
	2020	5,758	(.9)	705	(2.1)	6,565	.2	2,765	(3.7)	570	(.5)			2,532		5.2		1,268	(.3)
	2021	5,614	(2.5)	754	7.0	6,489	(1.2)	2,639	(4.6)	442	(22.5)			2,494		(1.5)		1,356	6.9
	2022	5,570	(.8)	755	.1	6,486	—	2,555	(3.2)	455	2.9			2,573		3.2		1,359	.2


2021	1	1,422	(4.1)	176	(.6)	1,628	(3.5)	696	(2.4)	111	(30.6)			600		(7.4)		331	1.5
	2	1,408	(3.4)	189	9.9	1,627	(1.8)	690	6.8	111	(17.2)			599		2.6		338	(20.7)
	3	1,393	(1.0)	191	9.1	1,616	.6	592	(12.8)	110	(22.0)			618		3.5		405	23.1
	4	1,391	(1.3)	197	8.2	1,619	.1	660	(9.2)	110	(18.5)			676		(3.8)		282	50.8

2022	1	1,413	(.6)	184	4.5	1,639	.7	666	(4.3)	114	2.7			640		6.7		333	.6
	2	1,394	(1.0)	193	2.1	1,628	.1	658	(4.6)	113	1.8			627		4.7		343	1.5
	3	1,375	(1.3)	185	(3.1)	1,598	(1.1)	616	4.1	114	3.6			638		3.2		345	(14.8)
	4	1,388	(.2)	192	(2.5)	1,621	.1	614	(7.0)	115	4.5			667		(1.3)		339	20.2

2023	1	1,428	1.1	197	7.1	1,660	1.3	651	(2.3)	119	4.4			657		2.7		352	5.7
	2	1,425	2.2	203	5.2	1,663	2.1	645	(2.0)	120	6.2			648		3.3		369	7.6
	3	1,419	3.2	209	13.0	1,661	3.9	510	(17.2)	122	7.0			674		5.6		478	38.6

Aflac U.S.


Operating Ratios
(Before Management Fee)




		12-Mo. Rolling			Total Adjusted	Combined	Pretax
		Premium	Tot. Ben./	Amort./	Expenses/	Ratio/	Profit
	Period	Persistency (1)	Premium	Premium	Total Adj. Rev.	Total Adj. Rev.	Margin

	2018	78.7		50.6	9.4	35.2	80.1	19.9
	2019	77.7		49.4	9.9	36.7	80.6	19.4
	2020	79.3		48.0	9.9	38.6	80.7	19.3
	2021	79.7		47.0	7.9	38.4	79.1	20.9
	2022	77.3		45.9	8.2	39.7	79.0	21.0
	2023 YTD	78.7		42.3	8.5	39.7	75.9	24.1

2021	1	80.0		48.9	7.8	36.9	79.6	20.3
	2	80.1		49.0	7.9	36.8	79.2	20.8
	3	80.0		42.5	7.9	38.2	74.9	25.1
	4	79.7		47.4	7.9	41.8	82.6	17.4

2022	1	78.7		47.1	8.1	39.0	79.7	20.3
	2	78.1		47.2	8.1	38.5	78.9	21.1
	3	77.9		44.8	8.3	39.9	78.4	21.6
	4	77.3		44.2	8.3	41.1	79.1	20.9

2023	1	77.9		45.6	8.3	39.6	78.8	21.2
	2	78.2		45.3	8.4	39.0	77.8	22.2
	3	78.7		35.9	8.6	40.6	71.2	28.8



(1) Includes Network Dental & Vision, Consumer Markets, and Group Premier Life, Absence Management, and Disability Solutions products beginning in the first quarter of 2021

Aflac U.S.


Aflac U.S. Sales Results
(Dollars In Millions)

		Annl.			New Annl.
		Prem.		%	Prem.		%
	Period	In Force		Change	Sales		Change

	2018		6,231	3.0		1,601	3.2
	2019		6,301	1.1		1,580	(1.3)
	2020		6,099	(3.2)		1,093	(30.8)
	2021		6,003	(1.6)		1,278	16.9
	2022		5,697	(.6)		1,483	16.1


2021	1		6,027	(3.2)		251	(22.1)
	2		5,988	(1.5)		264	64.1
	3		5,929	(.7)		299	35.0
	4		6,003	(1.6)		464	19.6

2022	1		5,942	(1.4)		299	19.0
	2		5,926	(1.0)		305	15.6
	3		5,889	(.7)		334	11.8
	4		5,967	(.6)		545	17.4

2023	1		6,023	1.4		315	5.3
	2		6,064	2.3		324	6.4
	3		6,062	2.9		359	7.5

Aflac U.S.


Aflac U.S. Product Mix
(New Annualized Premium Sales, Dollars in Millions)

				% of		% of		% of	Critical	% of	Hospital	% of	Dental/	% of
		Period	Disability	Total	Life	Total	Accident	Total	Care(1)	Total	Indemnity	Total	Vision	Total	Total
		2018	363	22.7	88	5.5	468	29.2	354	22.1	253	15.8	75	4.7	1,601
		2019	355	22.5	97	6.1	450	28.5	346	21.9	263	16.6	69	4.4	1,580
		2020	243	22.3	80	7.3	285	26.1	242	22.2	197	18.0	45	4.1	1,093
		2021	296	23.1	114	9.0	321	25.1	273	21.3	209	16.4	65	5.1	1,278
		2022	378	25.5	156	10.5	338	22.8	299	20.1	226	15.3	85	5.8	1,483


	2021	1	58	23.1	17	6.7	66	26.3	57	22.6	42	16.7	11	4.6	251
		2	60	22.7	19	7.3	72	27.2	56	21.0	43	16.4	14	5.4	264
		3	79	26.2	27	9.2	76	25.5	57	19.1	45	15.1	15	4.9	299
		4	100	21.4	51	11.0	107	23.1	104	22.3	79	17.0	24	5.2	464

	2022	1	70	23.3	24	7.9	75	25.3	63	21.2	50	16.7	17	5.6	299
		2	77	25.2	26	8.3	75	24.6	63	20.6	45	14.9	19	6.4	305
		3	97	28.9	33	10.0	76	22.6	60	18.1	47	14.1	21	6.3	334
		4	135	24.9	73	13.4	112	20.5	112	20.6	84	15.4	28	5.2	545

	2023	1	79	25.2	26	8.3	74	23.5	64	20.5	50	15.9	21	6.6	315
		2	80	24.8	35	10.7	73	22.4	66	20.4	46	14.3	24	7.4	324
		3	101	28.2	54	15.0	72	19.9	67	18.6	45	12.6	20	5.7	359


Aflac U.S. Sales Force Data

					Average	Productivity
					Weekly	(Production/
		Recruited Agents			Producer	Avg. Weekly
	Period	Career	Broker	Total	Equivalents	Producers)
	2018	15,774	3,380	19,154	8,531	187,720
	2019	15,227	3,603	18,830	8,184	193,120
	2020	11,826	1,861	13,687	5,918	184,706
	2021	10,641	5,445	16,086	5,993	213,235
	2022	9,550	1,500	11,050	6,186	239,786


2021	1	2,890	1,063	3,953	5,643	44,530
	2	2,754	1,355	4,109	5,925	44,540
	3	2,502	1,615	4,117	5,926	50,448
	4	2,495	1,412	3,907	6,477	71,723

2022	1	1,987	455	2,442	6,061	49,322
	2	2,937	391	3,328	6,067	50,264
	3	2,358	339	2,697	6,010	55,599
	4	2,268	315	2,583	6,607	82,538

2023	1	2,676	348	3,024	6,108	51,525
	2	2,801	399	3,200	6,196	52,361
	3	2,407	431	2,838	6,044	59,425

(1) Includes cancer, critical illness, and hospital intensive care products

Aflac Japan


Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)

		Years Ended December 31,										3 Months Ended September 30,					9 Months Ended September 30,
																%					%
		2018		2019		2020		2021		2022		2022		2023		Change	2022		2023		Change
Revenues:
	Net earned premiums
	Gross premiums	¥	1,468,894	¥	1,450,586	¥	1,409,134	¥	1,290,527	¥	1,246,657	¥	305,702	¥	304,456		¥	937,352	¥	913,996
	Assumed (ceded)		(60,198)		(57,974)		(55,926)		(50,864)		(48,578)		(12,034)		(19,151)			(36,588)		(58,265)
	Total net earned premiums		1,408,697		1,392,612		1,353,208		1,239,663		1,198,079		293,667		285,305	(2.8)		900,765		855,731	(5.0)
	Net investment income (1)
	Yen denominated		141,575		142,473		138,397		138,513		149,449		46,205		35,175	(23.9)		115,178		104,158	(9.6)
	US$ denominated		149,801		157,717		167,541		202,905		215,171		49,323		67,001	35.8		159,785		182,941	14.5
	Net investment income		291,377		300,191		305,938		341,419		364,621		95,528		102,176	7.0		274,964		287,100	4.4
	Amortized hedge costs on foreign investments (2)		(25,858)		(28,938)		(22,816)		(8,391)		(13,155)		(3,288)		(3,310)	.7		(9,677)		(19,340)	99.9
	Adjusted net investment income		265,519		271,253		283,122		333,028		351,466		92,241		98,866	7.2		265,287		267,760	.9
	Other income excl. realized foreign
	currency gains (losses)		4,636		4,869		4,497		4,512		4,442		1,205		1,192			3,420		3,561

	Total adjusted revenues		1,678,852		1,668,734		1,640,827		1,577,203		1,553,988		387,113		385,363	(.5)		1,169,471		1,127,052	(3.6)

Benefits and claims:
	Benefits and claims, net
	Incurred claims -direct		724,556		727,491		734,471		743,247		788,602		215,167		184,015			604,350		584,820
	Incurred claims -assumed (ceded)		(51,892)		(45,657)		(37,806)		(31,798)		(36,170)		(12,232)		(14,754)			(29,050)		(47,148)
	Increase in FPB -direct		313,343		292,444		260,200		149,084		73,592		1,352		22,311			47,723		36,954
	Increase in FPB -assumed (ceded)		(2,000)		(6,497)		(11,377)		(11,425)		(5,618)		(871)		(690)			(4,931)		(681)
	Total benefits and claims, net, excluding reserve remeasurement		N/A		N/A		N/A		849,108		820,405		203,416		190,881			618,093		573,945
	Reserve remeasurement (gain) loss		N/A		N/A		N/A		(6,879)		(13,337)		(7,295)		(5,027)			(10,275)		(9,510)
	Total benefits and claims, net		984,007		967,782		945,487		842,229		807,068		196,121		185,855	(5.2)		607,818		564,435	(7.1)

Adjusted expenses:
	Amortization of deferred policy
	acquisition costs		78,459		77,286		68,818		43,131		44,123		11,073		11,435	3.3		32,922		34,074	3.5
	Insurance commissions		81,045		79,661		79,036		77,449		73,482		18,326		16,113	(12.1)		55,327		51,934	(6.1)
	Insurance and other expenses		181,139		189,203		199,606		202,586		198,493		48,100		45,521	(5.4)		145,366		132,493	(8.9)
	Total adjusted expenses		340,643		346,150		347,460		323,166		316,097		77,498		73,068			233,616		218,501


	Total benefits and adjusted expenses		1,324,651		1,313,932		1,292,947		1,165,395		1,123,165		273,619		258,923	(5.4)		841,434		782,935	(7.0)

	Pretax adjusted earnings	¥	354,201	¥	354,802	¥	347,881	¥	411,808	¥	430,823	¥	113,494	¥	126,440	11.4	¥	328,037	¥	344,117	4.9


	(1) Includes the net interest cash flows from derivatives associated with certain investment strategies
	(2) See non-U.S. GAAP financial measures for the definition of amortized hedge costs/income

Aflac Japan


Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)

		Years Ended December 31,										3 Months Ended September 30,						9 Months Ended September 30,
																	%					%
		2018		2019		2020		2021		2022		2022			2023		Change	2022		2023		Change
Revenues:
	Net earned premiums
	Gross premiums	$	13,307	$	13,304	$	13,193	$	11,765	$	9,558	$	2,212		$	2,105		$	7,371	$	6,629
	Assumed (ceded)		(546)		(532)		(524)		(463)		(372)		(87)			(132)			(287)		(422)
	Total net earned premiums		12,762		12,772		12,670		11,301		9,186		2,125			1,973	(7.2)		7,084		6,207	(12.4)
	Net investment income (1)
	Yen denominated		1,283		1,307		1,296		1,262		1,140		335			243	(27.5)		898		755	(15.9)
	US$ denominated		1,356		1,446		1,569		1,845		1,641		357			462	29.4		1,251		1,320	5.5
	Net investment income		2,639		2,753		2,865		3,107		2,782		692			705	1.9		2,149		2,075	(3.4)
	Amortized hedge costs on foreign investments (2)		(236)		(257)		(206)		(76)		(112)		(28)			(26)	(7.1)		(84)		(148)	76.2
	Adjusted net investment income		2,403		2,496		2,659		3,031		2,669		663			679	2.4		2,066		1,927	(6.7)
	Other income excl. realized foreign
	currency gains (losses)		41		45		42		41		35		9			8			26		26

	Total adjusted revenues		15,206		15,313		15,371		14,373		11,889		2,797			2,660	(4.9)		9,176		8,160	(11.1)

Benefits and claims
	Benefits and claims, net
	Incurred claims -direct		6,566		6,671		6,875		6,776		6,038		1,550			1,273			4,736		4,250
	Incurred claims -assumed (ceded)		(471)		(419)		(354)		(290)		(275)		(88)			(102)			(225)		(342)
	Increase in FPB -direct		2,836		2,684		2,437		1,356		562		9			157			381		265
	Increase in FPB -assumed (ceded)		(18)		(60)		(107)		(104)		(43)		(6)			(9)			(40)		(9)
	Total benefits and claims, net, excluding reserve remeasurement		N/A		N/A		N/A		7,738		6,282		1,465			1,319			4,852		4,164
	Reserve remeasurement (gain) loss		N/A		N/A		N/A		(62)		(91)		(45)			(33)			(69)		(68)
	Total benefits and claims, net		8,913		8,877		8,851		7,675		6,191		1,420			1,286	(9.4)		4,783		4,097	(14.3)

Adjusted expenses:
	Amortization of deferred policy
	acquisition costs		710		709		644		393		338		80	55		79	(1.3)		258		247	(4.3)
	Insurance commissions		735		731		740		706		563		132			112	(15.2)		435		377	(13.3)
	Insurance and other expenses		1,640		1,734		1,873		1,843		1,517		347			315	(9.2)		1,140		960	(15.8)
	Total adjusted expenses		3,085		3,174		3,257		2,942		2,417		560			506			1,833		1,585

	Total benefits and adjusted expenses		11,998		12,051		12,108		10,618		8,609		1,980			1,791	(9.5)		6,616		5,682	(14.1)

	Pretax adjusted earnings	$	3,208	$	3,261	$	3,263	$	3,755	$	3,281	$	817		$	869	6.4	$	2,560	$	2,479	(3.2)


	(1) Includes the net interest cash flows from derivatives associated with certain investment strategies
	(2) See non-U.S. GAAP financial measures for definition of amortized hedge costs/income

Aflac Japan


Balance Sheets
(In Millions)


	December 31,											September 30,
	2018		2019		2020		2021		2022		2022			2023

Assets:

Investments and cash	¥	12,031,549	¥	12,847,994	¥	13,080,154	¥	13,645,902	¥	12,777,746		¥	13,468,243		¥	13,282,202
Receivables, net of allowance for credit losses		37,083		28,219		20,782		22,439		23,138			22,386			21,270
Accrued investment income		66,350		65,485		62,722		67,493		76,489			74,789			73,446
Deferred policy acquisition costs		708,638		721,341		723,579		745,510		766,506			762,434			783,890
Other assets		292,335		308,411		320,351		386,832		387,065			419,835			708,507

Total assets	¥	13,135,956	¥	13,971,450	¥	14,207,588	¥	14,868,176	¥	14,030,944		¥	14,747,687		¥	14,869,316


Liabilities and Shareholders' Equity:

Future policy benefits	¥	8,637,152	¥	8,924,868	¥	9,175,501	¥	11,755,704	¥	10,315,140		¥	10,760,419		¥	10,264,585
Policy and contract claims		317,043		315,477		328,778		—		28			—			433
Unearned premiums		552,419		453,133		361,010		284,045		227,732			240,184			200,677
Other policyholders' funds		793,148		801,588		808,429		877,690		880,989			882,823			879,922
Income taxes (prim. deferred)		510,528		618,901		478,969		36,166		114,688			121,155			136,978
Other liabilities		194,949		357,135		253,219		502,633		575,554			766,420			1,010,041
Shareholders' equity		2,130,718		2,500,349		2,801,682		1,411,938		1,916,812			1,976,686			2,376,680

Total liabilities & shareholders' equity	¥	13,135,956	¥	13,971,450	¥	14,207,588	¥	14,868,176	¥	14,030,944		¥	14,747,687		¥	14,869,316

Aflac Japan


Balance Sheets
(In Millions)


	December 31,										September 30,
	2018		2019		2020		2021		2022			2022			2023

Assets:

Investments and cash	$	108,392	$	117,269	$	126,378	$	118,639	$	96,290			$	93,006		$	88,797
Receivables, net of allowance for credit losses		334		258		201		195		174				155			142
Accrued investment income		598		598		606		587		576				516			491
Deferred policy acquisition costs		6,384		6,584		6,991		6,482		5,776				5,265			5,241
Other assets		2,634		2,815		3,095		3,363		2,917				2,900			4,737

Total assets	$	118,342	$	127,523	$	137,271	$	129,266	$	105,734			$	101,842		$	99,407


Liabilities and Shareholders' Equity:

Future policy benefits	$	77,812	$	81,461	$	88,652	$	102,206	$	77,733			$	74,307		$	68,623
Policy and contract claims		2,856		2,879		3,177		—		—				—			3
Unearned premiums		4,977		4,136		3,488		2,470		1,716				1,659			1,341
Other policyholders' funds		7,145		7,316		7,811		7,631		6,639				6,096			5,883
Income taxes (prim. deferred)		4,601		5,650		4,630		314		781				768			876
Other liabilities		1,756		3,260		2,447		4,369		4,337				5,293			6,753
Shareholders' equity		19,194		22,820		27,068		12,276		14,528				13,719			15,929

Total liabilities & shareholders' equity	$	118,342	$	127,523	$	137,271	$	129,266	$	105,734			$	101,842		$	99,407

Aflac Japan


Quarterly Statements of Pretax Adjusted Earnings and Percentage Changes
(Yen In Millions)


		Net						Total			Benefits						Total				Pretax
		Earned		%	Adjusted		%	Adjusted		%	&		%			%	Adjusted		%		Adjusted		%
	Period	Premiums		Change	NII		Change	Revenues		Change	Claims, Net		Change	Amort.		Change	Expense		Change		Earn.		Change

	2018		1,408,697	(1.5)		265,519	5.5		1,678,852	(.5)		984,007	(3.5)		78,460	11.0		340,642		5.2		354,201		3.1
	2019		1,392,612	(1.1)		271,253	2.2		1,668,734	(.6)		967,782	(1.6)		77,286	(1.5)		346,150		1.6		354,802		.2
	2020		1,353,208	(2.8)		283,122	4.4		1,640,827	(1.7)		945,487	(2.3)		68,818	(11.0)		347,459		.4		347,881		(2.0)
	2021		1,239,663	(8.4)		333,028	17.6		1,577,203	(3.9)		842,229	(10.9)		43,131	(37.3)		323,166		(7.0)		411,808		18.4
	2022		1,198,079	(3.4)		351,466	5.5		1,553,988	(1.5)		807,068	(4.2)		44,123	2.3		316,097		(2.2)		430,823		4.6


2021	1		313,769	(8.5)		74,621	6.9		389,679	(5.9)		215,445	(9.5)		10,534	(44.1)		77,715		(6.3)		96,519		3.8
	2		311,733	(8.3)		86,681	27.4		399,488	(2.4)		212,617	(10.4)		10,700	(35.9)		79,234		(3.0)		107,637		19.4
	3		307,350	(8.7)		84,035	19.7		392,463	(3.8)		206,023	(14.2)		10,762	(32.7)		80,760		(8.9)		105,680		33.5
	4		306,812	(8.1)		87,690	16.8		395,573	(3.5)		208,143	(9.5)		11,134	(35.6)		85,457		(9.3)		101,973		19.1

2022	1		304,884	(2.8)		79,042	5.9		385,000	(1.2)		206,890	(4.0)		10,886	3.3		77,095		(.8)		101,015		4.7
	2		302,213	(3.1)		94,004	8.4		397,358	(.5)		204,807	(3.7)		10,964	2.5		79,022		(.3)		113,529		5.5
	3		293,667	(4.5)		92,241	9.8		387,113	(1.4)		196,121	(4.8)		11,073	2.9		77,498		(4.0)		113,494		7.4
	4		297,315	(3.1)		86,180	(1.7)		384,517	(2.8)		199,250	(4.3)		11,201	.6		82,482		(3.5)		102,785		.8

2023	1		287,048	(5.9)		80,931	2.4		369,145	(4.1)		192,270	(7.1)		11,281	3.6		72,625		(5.8)		104,251		3.2
	2		283,377	(6.2)		87,963	(6.4)		372,544	(6.2)		186,310	(9.0)		11,359	3.6		72,808		(7.9)		113,426		(.1)
	3		285,305	(2.8)		98,866	7.2		385,363	(.5)		185,855	(5.2)		11,435	3.3		73,068		(5.7)		126,440		11.4

Aflac Japan


Operating Ratios
(Before Management Fee)

		12-Mo. Rolling		Tot. Ben./		Tot. Adj.	Combined	Pretax
		Premium	Tot. Ben./	Premiums	Amort./	Expenses/	Ratio/	Profit
	Period	Persistency(1)	Premium	(3rd sector)	Premium	Total Adj. Rev.	Total Adj. Rev.	Margin

	2018	94.1	69.9	59.2	5.6	20.3	78.9	21.1
	2019	94.4	69.5	59.3	5.5	20.7	78.7	21.3
	2020	95.1	69.9	59.7	5.1	21.2	78.8	21.2
	2021	94.3	67.9	58.7	3.5	20.5	73.9	26.1
	2022	94.1	67.4	58.5	3.7	20.3	72.3	27.7
	2023 YTD	93.5	66.0	56.2	4.0	19.4	69.5	30.5

2021	1	95.0	68.7	59.6	3.4	19.9	75.2	24.8
	2	94.7	68.2	59.0	3.4	19.8	73.1	26.9
	3	94.5	67.0	57.8	3.5	20.6	73.1	26.9
	4	94.3	67.8	58.4	3.6	21.6	74.2	25.8

2022	1	94.3	67.9	58.5	3.6	20.0	73.8	26.2
	2	94.3	67.8	58.5	3.6	19.9	71.4	28.6
	3	94.3	66.8	59.4	3.8	20.0	70.7	29.3
	4	94.1	67.0	57.7	3.8	21.5	73.3	26.7

2023	1	93.9	67.0	57.7	3.9	19.7	71.8	28.2
	2	93.8	65.7	56.2	4.0	19.5	69.6	30.4
	3	93.5	65.1	54.8	4.0	19.0	67.2	32.8

(1) Premium persistency presented on a 12-month rolling basis for all periods, rather than year to date

Aflac Japan


Aflac Japan Sales Results
(Yen In Millions, unless otherwise noted)



		Annl.			Third Sector
		Prem.			New Annl.			Total
		In Force		%	Prem.		%	New Annual.		%
	Period	(Billions)		Change	Sales		Change	Premium Sales		Change

	2018		1,527.1	(1.6)		88,813	1.6		95,894	1.1
	2019		1,489.3	(2.5)		72,836	(18.0)		79,697	(16.9)
	2020		1,426.5	(4.2)		45,110	(38.1)		50,852	(36.2)
	2021		1,360.6	(4.7)		48,977	8.6		54,764	7.7
	2022		1,301.0	(4.4)		47,998	(2.0)		54,765	—



2021	1		1,410.0	(4.4)		12,492	—		13,998	(.2)
	2		1,391.7	(4.5)		12,125	40.1		13,602	38.4
	3		1,375.0	(4.6)		11,275	1.0		12,605	—
	4		1,360.6	(4.7)		13,084	2.2		14,559	1.1

2022	1		1,345.6	(4.6)		10,679	(19.0)		11,925	(14.8)
	2		1,332.0	(4.3)		11,372	(6.2)		12,731	(6.4)
	3		1,315.7	(4.3)		12,639	12.1		13,884	10.2
	4		1,301.0	(4.4)		13,308	1.7		16,224	11.4

2023	1		1,281.4	(4.8)		10,952	2.6		13,213	10.8
	2		1,268.4	(4.8)		13,964	22.8		16,112	26.6
	3		1,257.4	(4.4)		13,606	7.7		15,600	12.4

Aflac Japan


Aflac Japan Product Mix
(New Annualized Premium Sales, Yen In Billions)

			% of		% of	Income	% of	Child	% of		% of	Ordinary	% of		% of
	Period	Cancer	Total	Medical	Total	Support	Total	Endowment	Total	WAYS	Total	Life Other	Total	Other	Total	Total
	2018	63.1	65.8	23.9	25.0	1.7	1.8	.3	.3	.5	.5	5.9	6.1	.5	.5	95.9
	2019	47.2	59.2	24.6	31.0	1.0	1.2	.2	.2	.4	.5	5.9	7.4	.4	.5	79.7
	2020	28.8	56.6	15.9	31.2	.5	1.0	.2	.4	.4	.7	4.8	9.5	.3	.6	50.9
	2021	27.0	49.2	20.4	37.2	.3	.5	.2	.3	.4	.8	4.9	9.0	1.6	3.0	54.8
	2022	30.9	56.5	14.6	26.6	.7	1.3	.2	.3	1.9	3.5	4.5	8.1	2.0	3.7	54.8


2021	1	6.4	45.4	6.1	43.3	.1	.6	—	.3	.1	.7	1.2	8.9	.1	.8	14.0
	2	6.7	48.9	5.4	39.7	.1	.6	—	.4	.1	.8	1.2	8.9	.1	.7	13.6
	3	6.3	49.9	4.6	36.3	.1	.5	—	.3	.1	.7	1.1	9.0	.4	3.3	12.6
	4	7.7	52.7	4.4	29.9	.1	.4	—	.3	.1	.8	1.2	8.6	1.1	7.3	14.6

2022	1	6.4	53.0	3.8	31.4	.1	1.1	.1	.3	.1	.7	1.1	9.0	.5	4.5	11.9
	2	6.8	53.4	3.8	29.9	.3	2.2	—	.2	.1	.8	1.2	9.2	.6	4.3	12.7
	3	8.4	60.1	3.7	26.4	.2	1.2	—	.2	.1	.6	1.0	7.7	.5	3.8	13.9
	4	9.5	58.2	3.4	20.8	.1	.8	.1	.4	1.6	10.1	1.1	7.2	.4	2.5	16.2

2023	1	7.9	59.9	2.7	20.8	.1	.6	.1	.6	1.2	8.9	1.0	7.3	.2	1.9	13.2
	2	10.9	67.7	2.8	17.5	.1	.4	.1	.4	1.0	6.6	1.0	6.1	.2	1.3	16.1
	3	10.3	65.6	3.1	20.0	.1	.4	.1	.4	.9	6.0	.9	6.1	.2	1.5	15.6

Aflac Japan


Aflac Japan Sales Force Data

			Number of Agencies by Type				Sales Contribution by Agency Type

		Period	Individual/ Independent Corporate	Affiliated Corporate	Bank	Total	Individual/ Independent Corporate	Affiliated Corporate	Bank	Licensed Sales Associates(1)	Recruited Agencies
		2018	8,453	1,392	371	10,216	40.1	55.3	4.6	109,482	85
		2019	7,683	1,343	367	9,393	45.7	50.0	4.3	109,265	77
		2020	7,231	1,312	361	8,904	52.3	42.6	5.1	111,886	48
		2021	6,779	1,283	360	8,422	51.1	43.7	5.2	111,854	62
		2022	6,159	1,239	359	7,757	49.5	46.5	4.0	110,259	38


	2021	1	7,142	1,308	360	8,810	54.3	40.6	5.1	112,252	13
		2	7,055	1,305	359	8,719	51.1	44.0	4.9	113,259	22
		3	6,898	1,299	360	8,557	49.9	43.8	6.3	112,100	13
		4	6,779	1,283	360	8,422	49.2	46.3	4.5	111,854	14

	2022	1	6,447	1,266	360	8,073	48.9	46.5	4.6	109,873	6
		2	6,335	1,255	359	7,949	48.4	48.1	3.5	110,096	12
		3	6,260	1,246	359	7,865	49.3	46.2	4.5	110,400	12
		4	6,159	1,239	359	7,757	51.2	45.4	3.4	110,259	8

	2023	1	6,056	1,232	359	7,647	50.9	45.4	3.7	109,769	4
		2	5,947	1,219	360	7,526	44.8	52.5	2.7	112,593	5
		3	5,843	1,211	360	7,414	44.4	51.9	3.7	112,795	6

(1) Excludes Dai-ichi Life, banks, Japan Post Group and Daido Life

Aflac Japan


Yen/Dollar Exchange Rates

				Yearly
		Closing	Qtr	Cum	%
	Period	Rate(1)	Avg	Avg	Change

	2018	111.00	N/A	110.39	1.6
	2019	109.56	N/A	109.07	1.2
	2020	103.50	N/A	106.86	2.1
	2021	115.02	N/A	109.79	(2.7)
	2022	132.70	N/A	130.17	(15.7)


2021	1	110.71	105.88	105.88	2.8
	2	110.58	109.48	107.79	.4
	3	111.92	110.11	108.58	(.9)
	4	115.02	113.70	109.79	(2.7)

2022	1	122.39	116.18	116.18	(8.9)
	2	136.68	129.39	122.79	(12.2)
	3	144.81	137.08	126.65	(14.3)
	4	132.70	141.87	130.17	(15.7)

2023	1	133.53	132.30	132.30	(12.2)
	2	144.99	137.53	134.97	(9.0)
	3	149.58	144.97	138.38	(8.5)







	(1) Closing rate is based on the latest available and published MUFG Bank Ltd. TTM mid-day exchange rate.

Corporate and Other


Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)

		Years Ended December 31,															3 Months Ended September 30,							9 Months Ended September 30,
																							%							%
		2018			2019			2020			2021			2022			2022			2023			Change	2022			2023			Change
Revenues:
	Total net earned premiums		$	208		$	200		$	194		$	180		$	145		$	35		$	83	137.1		$	112		$	258	130.4
	Net investment income (1)		77			88			80			(73)			30			16			2		(87.5)		11			24		118.2
	Amortized hedge income (2)		36			89			97			57			68			19			25		31.6		44			92		109.1
	Adjusted net investment income		113			177			177			(16)			98			35			27		(22.9)		55			116		110.9
	Other income		18			15			13			11			24			3			4		33.3		22			9		(59.1)

	Total adjusted revenues		339			393			384			175			267			73			115		57.5		189			384		103.2

Benefits and expenses:
	Total net benefits and claims		199			194			180			161			141			40			65		62.5		110			206		87.3
	Interest expense		120			133			164			165			162			44			39		(11.4)		123			109		(11.4)
	Other adjusted expenses		159			137			155			142			181			45			59		31.1		129			176		36.4

	Total benefits and adjusted expenses		478			464			499			469			485			129			163		26.4		362			490		35.4

	Pretax adjusted earnings		$	(139)		$	(72)		$	(115)		$	(293)		$	(218)		$	(56)		$	(49)	12.5		$	(173)		$	(107)	38.2


	(1) The change in value of federal historic rehabilitation and solar investments in partnerships of $64 and $19 for the three-month periods and $169 and $61 for the nine-month periods ended September 30, 2023, and 2022, respectively, is included as a reduction to net investment income. Tax credits on these investments of $63 and $19 for the three-month period and $171 and $63 for the nine-month periods ended September 30, 2023, and 2022, respectively, have been recorded as an income tax benefit in the consolidated statement of earnings.
	(2) See non-U.S. GAAP financial measures for the definition of amortized hedge cost/income

Non-U.S. GAAP Financial Measures

The Company defines the non-U.S. GAAP financial measures included in this document as follows:


•			Adjusted book value is the U.S. GAAP book value (representing total shareholders’ equity), less AOCI as recorded on the U.S. GAAP balance sheet. Adjusted book value per common share is adjusted book value at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value and adjusted book value per common share important as they exclude AOCI, which fluctuates due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measures for adjusted book value and adjusted book value per common share are total book value and total book value per common share, respectively.
•			Adjusted book value including unrealized foreign currency translation gains and losses is adjusted book value plus unrealized foreign currency translation gains and losses. Adjusted book value including unrealized foreign currency translation gains and losses per common share is adjusted book value plus unrealized foreign currency translation gains and losses at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value including unrealized foreign currency translation gains and losses, and its related per share financial measure, important as they exclude certain components of AOCI, which fluctuate due to market movements that are outside management's control; however, it includes the impact of foreign currency as a result of the significance of Aflac’s Japan operation. The most comparable U.S. GAAP financial measures for adjusted book value including unrealized foreign currency translation gains and losses and adjusted book value including unrealized foreign currency translation gains and losses per common share are total book value and total book value per common share, respectively.
•			Adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment is adjusted book value plus unrealized foreign currency translation gains and losses and pension liability adjustment. The Company considers adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment important as it excludes certain components of AOCI, which fluctuates due to market movements that are outside management's control; however, it includes the impact of foreign currency as a result of the significance of Aflac’s Japan operation. The most comparable U.S. GAAP financial measure for adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment is total book value.
•			Adjusted debt is the sum of notes payable, as recorded on the U.S. GAAP balance sheet, excluding 50% of subordinated debentures and perpetual bonds and all pre-funding of debt maturities. The Company considers adjusted debt important as it measures outstanding debt consistently with expectations of the Company’s rating agency stakeholders. The most comparable U.S. GAAP financial measure for adjusted debt is notes payable.
•			Adjusted debt including 50% of subordinated debentures and perpetual bonds is the sum of notes payable, as recorded on the U.S. GAAP balance sheet, excluding pre-funding of debt maturities. The Company considers adjusted debt including 50% of subordinated debentures and perpetual bonds important as it measures outstanding debt consistently with expectations of the Company’s rating agency stakeholders. The most comparable U.S. GAAP financial measure for adjusted debt including 50% of subordinated debentures and perpetual bonds is notes payable.


•			Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that cannot be predicted or that are outside management’s control. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest cash flows from derivatives associated with notes payable but excluding any nonrecurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company's underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.
•			Adjusted earnings excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company's business is conducted in Japan and foreign exchange rates are outside management’s control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.
•			Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign exchange risks in the Company's Japan segment or in Corporate and other. These amortized hedge costs/ income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the term of the hedge. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/ income.
•			Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the impact of interest cash flows from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management’s control, while excluding the components that are within management’s control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.
•			Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company’s investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.
•			Adjusted return on equity is adjusted earnings divided by average shareholders’ equity, excluding accumulated other comprehensive income (AOCI). Management uses adjusted return on equity to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of this financial measure is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The Company considers adjusted return on equity important as it excludes components of AOCI, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity is return on average equity (ROE) as determined using net earnings and average total shareholders’ equity.

EX-99.3 4 aflex993teleconferencespee.htm EX-99.3 Document

Third Quarter 2023

Earnings Call

Video Update

Max K. Brodén

November 1, 2023

For more information contact:

Investor and Rating Agency Relations

800.235.2667

aflacir@aflac.com

Aflac Worldwide Headquarters

1932 Wynnton Road

Columbus, GA 31999

Preliminary note: Forward-Looking Information and Non-U.S. GAAP Financial Measures

Forward-Looking Information

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. The company desires to take advantage of these provisions. This transcript contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as “expect,” “anticipate,” “believe,” “goal,” “objective,” “may,” “should,” “estimate,” “intends,” “projects,” “will,” “assumes,” “potential,” “target,” "outlook" or similar words as well as specific projections of future results, generally qualify as forward-looking. Aflac undertakes no obligation to update such forward-looking statements.